by user






Richard Gale and Gary Null, PhD.
September 28, 2009
A central principle of democracy is freedom of choice. We can choose our political party, our
religion, and the food we eat, but this does not seem to be the case when it comes to our medical
choices and our freedoms to make them. The underlying foundation upon which the entire
vaccine program rests is that they have been proven to be safe and effective. So much so, that if
people choose not to be vaccinated they are criticized for making irresponsible and unscientific
choices that will not only adversely affect themselves, but could also cause others—co-workers,
family and classmates—to become infected with the pathogens their bodies harbor.
The US Public Health Service and its various agencies—the FDA, CDC, NIAID, NIH and
CBER—oversee the distribution of information and the scheduling of vaccines, both voluntary
and mandatory, is. These Federal agencies are the guiding light for the primary information and
resources provided to Congressional oversight committees, and professional medical
organizations, such as the American Medical Association and the National Academy of Sciences.
From there, information and resources trickle down to the various state health commissioners,
who then present information to local health officials at the state level. In addition, they provide
the local media reports about pathogenic health threats and new scientific breakthroughs on
vaccines. At the Federal level, health agencies are responsible for doing either original research
or contracting out research initiatives to universities and pharmaceutical companies. Frequently,
both the government and the private vaccine makers work in partnership. At the end of the day,
conservatively, there are thousands of individuals who make policy decisions in our vaccine
industrial complex. As a result, the mainstream media has taken the position that whatever the
official word is about a vaccine, it goes virtually unchallenged. It becomes dogma. Those brave
enough to criticize vaccines (whether they are physicians, scientists, journalists or citizens) are
considered irresponsible, are discredited, immediately viewed with suspicion, which brings us to
our current dilemma.
Here in New York, the swine flu vaccine, followed by the seasonal flu vaccine, has been
mandated for all health care workers. The vaccine is being proposed in many other states. It is
already mandated for all members of the armed forces, as well as students in various colleges
and public health school systems. Simultaneously there is a growing number of voices
suggesting that they or their children’s injuries are due to individual or combinations of vaccines.
These include everything from Gulf War Syndrome to Autism Spectrum Disorders, debilitating
neurological and autoimmune conditions and preventable infant deaths. Furthermore, there are a
growing number of other disease epidemics, such as adult diabetes and cancers in children,
enormous increases in allergies and gastro-intestinal disturbances, whose etiologies remain
uncertain and may still be discovered to be attributable to the over-vaccination of the public. The
government and the entire vaccine industrial complex have responded to all of these allegations
by simply dismissing them as untrue and without proof. True science would interpret this as a
radical decision. Being told that if we don’t take a vaccine, then we will be fired immediately
without exemptions or options is an equally extremist attitude.
Therefore, we decided to ask four basic questions. These questions would determine the truth.
The first question: Are vaccines truly effective in protecting people based upon a gold standard
that can be applied to all other areas of science? If they are effective, what is the proof? Are
there long-term individual and multi-vaccine combination studies and double-blind placebo
control studies? Did these studies compare fully vaccinated groups of individuals against groups
that were non-vaccinated? Have there been trials that compared one group vaccination and
another put on a life style modification program?
Second question: Are vaccines safe? If so, what is the proof? How do we know whether a
vaccinated individual who didn’t come down with an infection that it is to the vaccine or whether
it is due to their immune system? How can we reconcile a very short timeframe used throughout
vaccine trials to determine safety, when much of the scientific literature shows delayed responses
for more serious adverse effects? How many people are excluded from being vaccine-injured
because the statutes of limitation ran out on them, although their injury was in fact due to a
vaccination? Also, how do we reconcile the very low number of adverse reactions that are
actually being reported by the CDC? In addition, when we study the Vaccine Compensation Act
over a billion dollars has been given to victims. How do we know whether a person will be
protected and the vaccine will be effective and safe, and what is the proof?
Questions three and four: Are vaccines not effective? If so, what is the proof? And if vaccines
are not safe, what is the proof?
After spending several years researching each of these four questions, our conclusions are
startling. Research and statistical studies show that no single vaccine and no combination of
vaccines have been proven to be effective or safe for any given individual. In addition, we found
that the vaccine process does not confer the protected immunization for a given individual. To
the contrary, vaccines may actually compromise and adversely altering the body’s immune
How could modern medicine have gotten this so wrong and for so long? How could the vast
majority of respected medical and health organizations—the American Medical Associations, the
pediatric community, prestigious medical schools, the federal scientific community, etc.—have
been so mistaken? And then why has the major media acted in such an irresponsible manner?
This brings us to questions that cannot be based on true science but rather on greed. Greed is
now something the average American is fully aware of. We have witnessed it on Wall Street,
with multinational banks, with the healthcare and insurance industries, and increasingly with
pharmaceutical companies who have an ever greater need for profits and now exploit their
enormous influence and buying-power over our government’s regulatory agencies. Legislators at
both the state and federal levels have permitted unwarranted influence by these same
pharmaceutical giants, lobbyists and consultants to influence how laws are written and how
funds are appropriated. Sadly, public policy and corporate liability have been directly written for
and by pharmaceutical interests.
This story is so vast, with so many details, that we have decided to release it in two parts. Due to
the urgency of a proposed state mandated swine flu vaccination, we are presenting first part that
focuses principally on the new H1N1 swine flu and influenza vaccines in general. The second
part will later examine in greater detail all the other vaccines. Our overall conclusion is that our
vaccine program requires crucial reform.
Dr. Viera Scheibner is arguably one of the world’s most respected scientists and scholars of
vaccine medical data. She is the author of Vaccination: 100 Years of Orthodox Research and
Behavioral Problems in Children: The Link to Vaccination, in addition to publishing almost 100
peer-reviewed papers. During a live radio broadcast on September 18, 2009, she shared an
overview of vaccine history and presented a more realistic definition of vaccination theory in
light of reviewing thousands of studies, articles and books written since Edward Jenner tested the
first vaccine in 1796. Her investigations uncover how the vaccine industrial complex, and
national and international agencies who oversee vaccination policies continue to entertain a
pseudo-science that is fraught with inconsistencies, poorly designed studies, erroneous
interpretations, and conclusions that are patently false. To take one simple example, practicing
physicians today will tell us there is no natural immunity for tetanus; therefore, a vaccination is
necessary. Yet, a large research study in India of over 70,000 people, none having received
tetanus injections, found most had natural immunity to the pathogen.
Dr. Scheibner fundamentally redefines the rationale and terminology applied to vaccine
“Ever since the turn of the century medical journals published dozens and dozens of
articles demonstrating that injecting vaccines [can] cause anaphylaxis, meaning harmful,
inappropriate immunological responses, which is also called sensitization. [This means
there is] increased susceptibility to the disease which the vaccine is suppose to prevent,
and to a host of related and other unrelated infections. We see it in vaccinated children
within days, within two or three weeks. Most vaccinated children, but not all, develop
runny noses, ear infections, pneumonitis , bronchiolitis. It is only a matter of degrees,
which indicates immuno-suppression. So it doesn’t indicate immunity. It indicates the
opposite. So I never use the word immunization because that is false advertising. It
implies that vaccines immunize, which they don’t. The correct term is either vaccination
or sensitization.”
“Vaccines [cam] damage internal organs, particularly the pancreas… So not only is it that
children develop these infections with increased severity, but they develop… these
autoimmune diseases like diabetes. That’s a real pandemic….[Vaccination] is an illness
industry. They cause pandemics of diabetes. They cause pandemics of other degenerative
diseases. They cause pandemics of behavioral problems.”
“The term immunization should be outlawed because it’s a lie. It’s false advertising.
Vaccination is the right term because it simply means injecting a vaccine. The word
immunization implies vaccines prevent disease… They actually [may lead to] them. If
they don’t want to use the word vaccination, they should use the word sensitization.1
Although there are numerous voices against vaccination, and even more against mandatory
vaccination, it is equally important to bring attention to the words of dissent from within the
government health agencies and the vaccine industrial complex. For example, in November
2007, the UK newspaper The Scotsman, made public warnings by the inventor of the “flu jab,”
Dr. Graeme Laver. Dr. Laver was a major Australian scientist involved in the invention of a flu
vaccine in addition to playing a leading scientific role in the discovery of anti-flu drugs. He went
on record as saying the vaccine he helped to create was ineffective and natural infection with the
flu was safer. “I have never been impressed with its efficacy,” said Dr. Laver.2
Vaccines are suspensions of infectious agents used to artificially induce immunity against
specific diseases. The aim of vaccination is to mimic the process of naturally occurring infection
through artificial means. Theoretically, vaccines produce a mild to moderate episode of
infection in the body with only temporary and slight side effects. But, in reality, they may be
causing diseases rather than preventing them. According to Jamie Murphy, an investigative
journalist on vaccines and author of What Every Parent Should Know About Childhood
Vaccination, “Vaccines produce disease or infection in an otherwise healthy person... And so, in
order to allegedly produce something good, one has to do something bad to the human body, that
is, induce an infection or a disease in an otherwise healthy person that may or may not have ever
When children contract a disease such as measles or mumps, they generally develop a permanent
protection against that disease. Such is not necessarily the case with vaccines. As Murphy
observes, “The medical profession does not know how long vaccine immunity lasts because it is
artificial immunity. If you get measles naturally, in the vast majority of cases you have lifelong
immunity..... However, if you get a measles vaccine or a DPT vaccine, [it does not guarantee
100% immunity] that the vaccine will prevent you from getting the disease.”3
Murphy continues: “You have a situation in which everyone is being given a disease with no
control over that disease, because once you inject a vaccine into a person’s body, whether it
contains bacteria or viruses or split viruses or whatever--you have no control over the outcome.
It’s like dumping toxic wastes into a river and saying, ‘If we just put a little bit in, it won’t
pollute the river. It will be just enough to do what we want it to do.’ Of course, what they want
the vaccination to do is initiate the building up of our immune defenses, just like a regular
infection would do. The problem is that the medical profession and science do not know, and
have never known, what the infecting dose of an infection really is. It’s not something that can
be measured. So they’re really guessing at the amount of antigen and other supplementary
chemicals that they put in the vaccine.”
“Vaccines are portrayed as being indispensable and somehow better at disease protection
than what our innate biological defenses and nutritional resources have accomplished for
thousands of years. I think it’s the height of arrogance for the medical profession to think
that they have duplicated a biological process that has taken care of people since the
beginning of time. People can deal with infectious diseases without vaccines. Before the
introduction of the measles and mumps vaccines, children got measles and they got
mumps, and in the great majority of cases those diseases were benign.”
“The most important point I want to make is that there’s no logical reason for having a
vaccine when these [natually occuring] infectious agents...can stimulate the immune
system to take care of that disease by itself. We don’t need anything artificial to do that
for us.”4
Walene James, founder of the organization Vaccine Liberation and author of Immunizations: The
Reality Beyond the Myth,5 adds that the full inflammatory response is necessary to create real
immunity, and reports that in The Lancet on June 5, 1985, there was an article about measles
virus infection relating to a variety of diseases in adult life. Researchers in Denmark, the article
explained, examined the histories of people claiming not to have had measles in childhood, yet
who had blood antibody evidence of such infection. The researchers found that some of these
people had been injected in childhood with the measles vaccine after exposure to the infection.
This may have suppressed the disease which was at the time developing in their bodies. A high
percentage of these individuals were found in adult life to have developed immunoreactive
diseases, such as sebaceous skin diseases, tumors, and degenerative diseases of bone and
cartilage. The conditions included cancer, MS, lupus, and chondromalacia, which is softening of
the cartilage.6
James quotes Dr. Richard Moskowitz, past president of the National Institute of Homeopathy,
and a cum laude graduate of Harvard and New York Medical School, as stating, “Vaccines trick
the body so that it will no longer initiate a generalized inflammatory response. They thereby
accomplish what the entire immune system seems to have evolved to prevent. They place the
virus directly into the blood and give it access to the major immune organs and tissues without
any obvious way of getting rid of it. These attenuated viruses and virus elements persist in the
blood for a long time, perhaps permanently. This, in turn, implies a systematic weakening of the
ability to mount an effective response, not only to childhood diseases but to other acute
infections as well.’
Further, Jamie Murphy insists that introducing antigens directly into the bloodstream can prove
dangerous. “When a child gets a naturally occurring infection, like measles, which is not a
serious disease, the body reacts to that in a very set way. The germs go in a certain part of the
body through the throat and into the different immune organs, and the body combats the disease
in its own natural way. There are all sorts of immune reactions that occur. Inflammatory
response reactions, macrophages, and different kinds of white blood cells are used to combat the
virus. You also cough and sneeze and get rid of the virus that way.
“When you inject a vaccine into the body, you’re actually performing an unnatural act
because you are injecting directly into the blood system. That is not the natural port of
entry for that virus. In fact, the whole immune system in our body is geared to prevent
that from happening. What we’re doing is giving the virus or the bacteria carte blanche
entry into our bloodstream, which is the last place you want it to be. This increases the
chance for disease because viral material from the vaccine stays in the cells, and is not
completely defeated by the body’s own defenses. You overload the body.”
In his widely circulated critique of vaccines, “Vaccination: Dispelling the Myths,” Alan Phillips,
a national health attorney and legal expert on vaccine policy, writes, “The clinical evidence for
vaccination is their ability to stimulate antibody production in the recipient, a fact which is not
disputed. What is not clear, however, is whether or not such antibody production constitutes
immunity. For example, a-gamma globulinemic children are incapable of producing antibodies,
yet they recover from infectious diseases almost as quickly as other children....Natural
immunization is a complex phenomenon involving many organs and systems; it cannot be fully
replicated by the artificial stimulation of antibody production. Research also indicates that
vaccination commits immune cells to the specific antigens involved in the vaccine, rendering
them incapable of reacting to other infections. Our immunological reserve may thus actually be
reduced, causing a generally lowered resistance.”7
Echoing the thinking of Walene James, Phillips adds: “Another component of immunization
theory is ‘herd immunity,’ which states that when enough people in a community are immunized,
all are protected. There are many documented instances showing just the opposite--fully
vaccinated populations do contract diseases; with measles, this actually seems to be the direct
result of high vaccination rates. A Minnesota state epidemiologist concluded that the HiB
vaccine increases the risk of illness when a study revealed that vaccinated children were five
times more likely to contract meningitis than unvaccinated children.”8
Across the media, the World Health Organization, the FDA and CDC have been reporting that
the swine flu threat is pandemic. So, why is this particular strain of influenza a pandemic when
every flu season is also a pandemic: it infects multiple people in multiple countries? Dr. Sherri
Tenpenny, one of America’s most knowledgeable physicians opposing vaccine theory, states that
there is technically no difference in calling this particular flu stain a pandemic threat compared to
any other.9 Why is this occurring during this particular flu season? And why are we being
warned of a pandemic with such urgency and warming, when prior flu seasons were not
advertized as such and, nevertheless, by the vast majority known conclusive scientific indicators
were much less severe than what we have witnessed with the H1N1 virus so far? Although
reports from scientists around the world are starting to admit that infection rates, symptoms and
mortality for this particular H1N1 strain are milder than other flu viruses.
Dr. Tom Johnson, the epidemiologist for the Cochrane Database Group, said in an interview for
the German magazine Der Spiegel on July 21, 2009: “Sometimes you get the feeling that there is
a whole industry almost waiting for a pandemic to occur. The WHO and public health officials,
virologists and the pharmaceutical companies. They’ve built this machine around the impending
pandemic. And there’s a lot of money involved, and influence, and careers, and entire
institutions! And all it took was one of these viruses to mutate to start the machine grinding.”
As of September 4, 2009, the World Health Organization has reported 2,837 deaths from H1N1
infection. The WHO report further claims 250,000 have been infected worldwide; however,
these numbers are unconfirmed. The United Nations argues the number is much higher. At the
same time, the UN earlier has relieved its member countries from reporting individual cases of
H1N1 infection.10 The media continues to make the threat look much worse than it might
actually be. For example, China, with a population of 1.3 billion people, reported 5,592 cases
and no deaths. Given the enormous population size compared to the US, this is far less serious
than a mild normal flu season, yet it is being reported to the world as “a grim situation.”11
However, when we look at the government’s official statistics of a normal flu season, there is no
indication that the new H1N1 strain poses now nor will it pose in any foreseeable future a
pandemic warranting the current extreme level of alarm. For Canada, the Canadian Medical
Association Journal reports that annual flu infection kills approximately 2,500 of its citizens, and
about 36,000 Americans, which is the CDC’s annual estimate. Worldwide, annual flu deaths
range between 250,000 and 500,000.12 In Mexico, which first brought attention to a new H1N1
strain, there were 176 flu deaths, yet only 7 of these deaths were corroborated by laboratory
analysis and confirmed to be the new H1N1 swine flu strain.13
As we enter the flu season this autumn and into winter, the Southern hemisphere is now leaving
its flu season and entering spring and summer. Our officials and media appear to be ignoring the
reports from the developed global South, such as Australia, and pushing forward with a media
blitz, predicting a dreadful scenario that will infect millions and kill thousands of people.
However, scientists and researchers in the developed South have reported that, although many
were infected, the symptoms have been mild and figures for hospitalization are exceptionally
low. Even global South politicians concur with scientists that the risk of a H1N1 epidemic
reoccurring there is over.14
Peter Doshi, a doctoral student at Massachusetts Institute of Technology, has performed a
thorough comparative analysis of several flu pandemics. His conclusions, published in the
prestigious British Medical Journal, predict that the H1N1 swine flu is of “the same subtype as
seasonal H1N1 that has been circulating since 1977.”15 He believes we may be witnessing
substantial confusion between the high public attention the present H1N1 scare is receiving and
the very low level of scientific certainty that H1N1 is more severe than other seasonal influenza.
Determining what influenza strains should be included in a vaccine is nothing more than a
prediction. There is no true science involved, which is why there are so many instances when the
flu season arrives, the viruses in the vaccine do not have a close match with the virus the
scientific community had predicted. Dr. R. Neustaedter describes the methods that the CDC use
to make their predictions for which viral strains the vaccine industrial complex should develop
for each forthcoming flu season. Their predictive methods are bizarre when reviewed rationally.
The history of the flu vaccine reads like one stumbling fiasco after another. Take an
example. Ever wonder how the particular viruses are chosen for next year’s vaccine? The
answer could be drawn from a 1930s film noir of Shanghai Villainy. Scientists kill
migrating ducks in Asia, culture the viruses and put those in next year’s vaccine, because
they have seen an association between bird and pig viruses and the following year’s
human flu epidemics. Perhaps this desperate guesswork is responsible for so many years
when the flu vaccines had nothing in common with circulating virsues.”16
How accurate have been the CDC’s predictions? For the 1992-1993 flu season, the prediction
made for the virus used in the vaccine was off by 84 percent. For the 1994-1995 season, it was
off by43 percent for the primary strain targeted and off 87 percent and 76 percent for the other
two strains. The Laboratory Center for Disease Control’s study comparing vaccine strains with
the strains appearing during the 1997-1998 season found the match was off by 84 percent. A
person might consider that it may be more accurate to simply flip a coin.
Dr. Katherin Severyn, who monitors prediction results and compares them with CDC claims,
makes the comment:
“Despite the poor track record in predicting which influenza viruses will infect communities, the
CDC claims that influenza vaccine is ‘approximately 70%’ effective in preventing influzenza in
“healthy persons less than 65 years of age,’ if ‘there is a good match between vaccine and
circulating viruses”17 Depending on the study cited, vaccine efficacy actually ranges from a low
of 0% to a high of 986%. And… the CDC often finds it difficult to match vaccines with
circulating viruses.18
An article published in the prestigious British Medical Journal in 2005, “Are US Flu Death
Figures More PR Than Science” is apropos for addressing the wildly inflated figures by the
WHO and CDC to present their case for mass vaccination measures. The article begins, “US
data on influenza deaths are a mess.” The study reviews the CDC’s own statistical data and finds
numerous inconsistencies and incompatibilities between “official estimates and national vital
statistics data.” Although the government’s predictions never came close to the “dire outcomes”
being stated by health officials, the CDC’s own communication strategy was marked by high
levels of fear.19
What few people recognize is that the majority of flu vaccine programs are purchased by the US
government for distribution; therefore, in the current H1NI flu predictions, the government
through the National Immunization Program (NIP) will be purchasing millions of vaccine units.
This is one major incentive for the CDC’s and HHS’s large media blitz upon the public to
encourage flu vaccination every year. The NIP does not want to be sitting with stockpiles of
unused, purchased vaccines. There is a strong financial incentive for pushing their cause for mass
The CDC Misinterprets Influenza Death Statistics
The official CDC website states that approximately 36,000 Americans die from the flu annually.
We repeatedly hear this figure reported by officials and in the media across the nation, hence
making flu infection the seventh cause of death in the US. But the reality is very different. The
CDC’s own website reports mortality rates under the frequent heading “influenza/pneumonia.”
Dr. David Rosenthal, Director of Harvard University’s Health Services, brings clarity to this
confusion. Most of these so-called flu deaths are in fact pneumonias—not even viral
pneumonias—and secondary infections. Furthermore, a study in the Journal of the American
Medical Academy shows that many of these deaths are a result of pneumonias acquired by
patients taking stomach acid suppressing drugs.
For example, if we are to take the combined figure of flu and pneumonia deaths for the flu period
of 2001, and add a bit of spin to the figures, we are left believing that 62,034 people died from
influenza. The actual figures are 61,777 died from pneumonia and only 257 from flu. Even more
amazing, in those 257 cases, only 18 were scientifically identified as positive for the flu virus. A
separate study conducted by the National Center for Health Statistics for the flu periods between
1979 and 2002 reveals that the range of annual flu deaths were between 257 and 3006, for an
average of 1,348 per year.20
How does the CDC respond to this discrepancy reported by the Harvard scientist? Read
carefully the CDC’s own statement.
“Typically, influenza causes death when the infection leads to severe medical
complications… [and as most such cases] are never tested for virus infection… CDC
considers these figures to be very substantial undercounting of the true number of deaths
from influenza. Therefore, the CDC uses indirect modeling methods to estimate the
number of deaths associated with influenza.” In an earlier 2003 article JAMA, William
Thompson from the CDC’s National Immunization Program attempted to explain
“influenza-associated mortality.” He wrote, “Based on modeling, we think it’s associated.
I don’t know that we would say that it’s the underlying cause of death.”21
In summary, the CDC is admitting 1) the deceased are not tested to determine the presence of the
flu virus, and 2) they do not directly perform any direct testing to determine the exact cause of
death but rather “indirect modeling methods” is a professional way of saying subjective
mathematical equations to arrive at their figures. The 36,000 mortality figure is nothing more
than a mathematical model. The British journal concluded that the only possible rationale for the
CDC’s complete disregard for scientific fact, even in face of independent research to discredit its
statistics, is a public relations effort between the CDC and the vaccine manufacturer’s campaigns
to increase flu vaccination.
There can be little doubt about this after statements presented by the CDC’s National
Immunization Program’s spokesperson, Glen Nowak, at the 2004 National Influenza Vaccine
Summit—co-sponsored by the CDC and the American Medical Association. Nowak outlined the
CDC’s “Seven Step Recipe for Generating Interest In, and Demand for, Flu Vaccination.” One
step requires “medical experts and public health authorities publicly.. [to] state concern and
alarm (and predict dire outcomes)” to encourage influenza vaccination. Another step is
“continued reports.. that influenza is causing severe illness and/or affecting lots of people,
helping to foster the perception that many people are susceptible to a bad case of influenza.” 22
Why was the “Seven Step Recipe” implemented? Dr. Nowak publicly stated the CDC’s reasons
on National Public Radio, “… the manufacturers were telling us that they weren’t receiving a lot
of orders for vaccine for use in November or even December [of 2003]… It really did look like
we [CDC] needed to do something to encourage people to get a flu shot.23
Now that we have a better understanding of how the CDC calculated its statistics in the past and
expert confirmation from renown publications and scientists that such data is erroneous, what do
we find on the CDC website under the heading “Influenza Death Statistics” as of September
2009—five years after the published denunciation of the CDC’s erroneous calculations for
“For pneumonia and influenza (P&I) deaths, CDC estimates approximately 8,000 deaths
are associated with seasonal flu. This represents 9.8% of (P&I) deaths. For respiratory
and circulatory (R&C) deaths, CDC estimates approximately 36,000 deaths are
associated with seasonal flu. This represents 3.1 percent of those deaths. For all-cause
deaths, CDC estimates that approximately 51,000 deaths are associated with seasonal flu.
This represents 2.2% of all deaths. Centers for Disease Control. “Influenza death
statistics”. www.cdc.gov/flu/about/diseases/us_flu-related_deaths.htm Accessed
September 24, 2009.
How did the CDC arrive at these conclusions? The CDC site now continues to restate its
scientifically flawed methodology: “Statistical modeling was used to estimate how many flurelated deaths occurred among people whose underlying cause of death on their death certificate
was listed as a respiratory and circulatory disease.”24 This is clearly an indication of policy
turned dogmatic that disregards sound scientific evidence proving their errors. It is all business
as usual, disregard the critics, full speed ahead.
Canadian health authorities are at least a bit more transparent over their investigations into
vaccination results than the American government health cartel. However, like the US, they still
report completely erroneous conclusions based on their own data. Every year Health Canada
publicizes their laboratory results of swabs received from people with Influenza-Like Illnesses
(ILI). Consistently the statistics show that approximately 95 percent of cases are attributable to
pathogens, such as adenoviruses, rhinoviruses, parainfluenza and others, instead of the flu
virus.25 Clinically, the symptoms appear very much the same, and unless laboratory tests with
high specificity are performed, nobody can distinguish between what is a real flu infection from
what might be any large number of different pathogenic infections giving flu-like symptoms.
During the 2004-2005 flu season, the Canada Communicable Disease Report showed that of the
68,849 laboratory tests performed for influenza, only 14.9% tested positive for a flu virus. All
the remaining 85.1% specimens were a result of other pathogens impervious to flu vaccines.26
For the following 2005-2006 season, Health Canada received 68,439 confirmed tests for
influenza like infections. Of these, only 6,580, or 10.4% confirmed positive for influenza. The
rest, 89.6%, were other pathogens.27 Canadian health officials, nevertheless, disregarded their
own statistics and continue their public relations campaign to boost the perception that the flu
vaccine is 70-90% effective. In a debate published in the Canadian Medical Association
Journal, Italian epidemiologist Dr. Vittorio Demicheli, now a colleague of Dr. Tom Jefferson,
stated that Canada’s claims are “both wrong and misleading… and refers only to the ability of
the vaccine to produce antibodies effective against the virus. But his is not the important measure
of vaccine efficacy. Instead, we should measure the ability of the vaccine to prevent clinical
disease, in this case influenza. By this measure, vaccine efficacy is no greater than 25%.”28
To further complicate matters regarding influenza-like-illnesses attributed to non-influenza
pathogens, there is also evidence showing that flu symptoms are synonymous with symptoms
caused by toxic levels of pesticides, herbicides and fluoride. During his sworn testimony before a
Congressional Hearing in the 1960s, Dr. Granville Knight, former president of the American
Academy of Nutrition, stated, “waves of so-called ‘Virus X’ and similar diseases… are caused
by exposure to such agricultural chemicals; [and] that it is impossible for doctors to diagnose the
difference between London flu, virus conditions and pesticide poisoning.”29
In August 2009, Swiss immunologist Dr. Beda Stadler at the Institute of Immunology at the
University of Bern reported in European papers that based on his research and analysis, the
swine flu has already ended through much of Europe and the United States. Dr. Stadler claims
“the dangerous pandemic virus has mutated into a simple summer flu.”30 A similar, yet
independent conclusion on September 1, 2009 from the University of Maryland predicts the
H1N1 will very unlikely mutate “in a natural way” into a more virulent virus.31 It would appear
therefore that any dangers for a new and more virulent strain of H1N1 emerging would more
readily be the result of vaccination. The important word in this is “in a natural way.” What is not
being taken into consideration in any manner by the vaccine industrial complex is the fact that
human bodies are also superb incubators for viruses, and perhaps introducing viruses into our
bloodstream, along with the numerous known and unknown genetic contamination found in
vaccines, are giving rise to new strains of virus. However, chasing the origins of a new strain of
flu virus would be as successful as standing on a beach and trying to find that one sand granule
that is older than all the others.
The Wall Street Journal in April 2009 reported that the WHO grossly inflated the number flu
deaths they reported as much as 15-fold. The actual confirmed swine flu deaths in Mexico were
7 instead 152. When the CDC reports flu mortality statistics, they are lumped in the same
category with all pneumonia deaths. According to the independent vaccine journalist, Wynne
Alexander, “this is patently ridiculous… this is just insanity on its face, and the CDC is
comfortable with that.”32 If we think for a moment only about the number of deaths among the
elderly from pneumonia infection, and then consider that the figures being published by the
government health agencies to support their dire warnings for a presumed epidemic in October
include pneumonia deaths, then it should be clear that H1N1 infection dangers are far less than
the government and vaccine makers want the nation to believe. This conclusion is actually
supported by relatively recent study published by the National Institutes of Health in 2005 that
surveyed three decades of data on mortality rates among the elderly. The study, aired on Canada
TV, discovered that flu shots for elderly American citizens did not save any lives.33
Small children between 6 and 24 months are being recommended for the front of the vaccination
line by the CDC. The agency’s rationale remains unclear. However, biologists at Clemson
University have determined that children under the age of 5 are the least likely to transmit swine
flu. Therefore, the researchers recommend that smaller children not be given such a high ranking
on the government’s priority risk group list.34
The chairman of the Health Committee in the German Parliament, Dr. Wolfang Wodarg, stated
to the Neuen Presse that the swine vaccine and the so-called pandemic “is great business for the
pharmaceutical industry.”35 In actual fact, the majority of independent science, unbiased by
pharmaceutical corporate support, has very well shown that the swine flu is not very different
from normal season flu and does not warrant any special, dramatic alarm.
Dr. Marc Girard is a medical specialist in drug adverse effects. He was commissioned by the
French courts as a medical witness on the swine flu vaccine’s safety. During an interview on
French television, Dr. Girard stated, “A vaccine is being developed in conditions of amateurism
such as I have never seen before. Let’s take the pessimistic hypothesis: one death among every
1000 patients. There are plans to vaccinate 60 million people, and so you already have 60,000
deaths, and this time, young people, children and pregnant women.” Dr. Viera Scheibner
comments on this scenario: “The swine flu vaccination is just a hoax. It’s an attempt to create a
pandemic so that they can sell a lot of vaccines.”36
According to Nancy Cox, Director of the Influenza Division at the Centers of Disease Control,
“intensive analysis” studies seem to indicate that the novel H1N1 variant has lower respiratory
transmission than the common seasonal H1N1 flu.37
The WHO is estimating that 2 billion or approximately one third of the world’s population might
become infected during the course of the next two years. In the US, the Centers for Disease
Control estimates that “swine flu could strike up to 40 percent of Americans.”38 For this reason,
world and national health agencies are mobilizing rapidly a massive vaccination campaign to
vaccinate as much of the planets population as possible. The Director General of the WHO, Dr.
Margaret Chan, estimates that vaccine makers could produce 4.9 billion pandemic flu shots.39
International scholar of political and social affairs, Michel Chossudovsky, states, “There is ample
evidence, documented in numerous reports, that the WHO’s level 6 pandemic alert is based on
fabricated evidence and a manipulation of the figures on mortality and morbidity resulting from
the H1N1 swine flu.” Chossudovsky has uncovered evidence that the CDCP and WHO are
“recategorizing a large number of cases of common influenza as H1N1 swine flu.”40
Across the developed world there is a growing distrust in the pharmaceutical and vaccine
industry, government health agencies and professional medical associations. Although the
National Vaccine Injury Compensation Program has paid out $1.2 billion in damages due to
vaccine adverse effects in children, the vaccine makers impose gag orders to prevent public
disclosure of vital proprietary information during settlements. There remains confusion among
the US health agencies on the actual percentages of vaccine adverse reactions. The FDA
estimates only 1 percent are reported; the CDC claims it is 10 percent. According to the National
Vaccine Information Center, only one in forty New York doctors report adverse reactions, and
medical students have testified before Congress that they were instructed to not report vaccine
incidents in their private practice. The recent authorization of the 2006 Public Readiness and
Emergency Preparadness Act provides vaccine manufacturers with legal impunity in the event
the new untested Swine Flu vaccines result in a wave of serious injury and death.41 Immediately
this raises the question why the drug lobbyists would insist upon being granted immunity. Cout it
be because they know the potential dangers of their swine flu vaccines? It is therefore little
wonder that more and more healthcare practitioners and the public are growing increasingly
suspicious of vaccine safety and the real intentions of the vaccine makers.
Suspicions also lie in the government’s figures to support their predictions of a 2009-2010 swine
flu threat based on evidence that the diagnostic kits being used are inaccurate in diagnosing the
presence of H1N1. There are currently three rapid diagnostic tests for determining swine flu
infection. A CDC report found that these tests can be wrong as much as nine out of ten times,
and on average between 40-69 percent. The CDC determined that the instant tests are “not highly
worthwhile for diagnosing H1N1 infections.” The report states that there is almost nothing to
distinguish the swine flu from normal seasonal flu. In fact, the diagnostic tests were more
accurate with the seasonal flu.42 Consequently, only professional diagnostic laboratories qualify
for scientifically sound diagnosis of H1N1 incidents. Reports are coming into the CDC from
many various venues and the most common diagnostic usage being used around the world are
these rapid diagnostic kits.
Throughout the world, healthcare practitioners, including physicians, are becoming nervous
about the reports about the swine flu vaccine and are turning suspicious about health officials’
hype over their dire warnings of swine flu’s dangers. Dr. Neal Rau, an Ontario medical director
of infection prevention and control told the Toronto Star, “I won’t get one until there have been a
million doses given and there is evidence it is safe.”43 Polls taken in European countries show an
increase in the number of health workers and citizens ready to refuse the H1NI vaccination.
Twenty-nine percent of all Germans surveyed said they would refuse the vaccine “under any
circumstance” and an additional 33 percent would likely refuse it. In the region of Bavaria and
Baden Wurtteemburg, only 10 percent of those polled said they would submit to the injection. In
France, Le Figaro conducted a poll of 12,050 people showing 69 percent would refuse it. In a
separate French survey, one third of 4,752 doctors, nurses and healthcare workers surveyed
would not be inoculated.44
In the UK, a couple polls reported in the Daily Mail in late August 2009, showed:
Half of family physicians do not want swine flu vaccination
Seventy-one percent of those polled do not believe the vaccine has been tested enough for
safety and the swine flu is much milder than health authorities are saying
A third of UK nurses would refuse the vaccine45
A survey published in the British Medical Journal of 8,500 healthcare workers in Hong Kong
found that more than fifty percent would refuse the swine flu vaccine if they could.
Polls taken in the US so far are showing Americans are quickly losing faith in the federal health
agencies’ and the private medical establishment’s assurances about vaccine efficacy and safety.
A poll of pregnant mothers taken by the parent support group Mumsnet.com indicates that
women are becoming more suspicious of vaccines’ ultimate value. The survey of 1500
respondents showed that only 6 percent of pregnant women would “definitely” take the shot,
while 48 percent said they “definitely” wouldn’t. The figures mirror an accompanying poll that
showed 5 percent definitely would and 46 percent definitely wouldn’t vaccinate their children.46
Another reason to question the health agencies’ credibility concerns the rapid push to have
sufficient amounts of the drug Tamiflu to treat people with H1N1 infections. This may seem to
be a vital and appropriate proactive measure if it wasn’t for the fact that two separate peerreviewed studies—one in the March 2009 Journal of the American Medical Association and the
other in the New England Journal of Medicine—stated Tamiflu does not work for the H1N1
virus! The conclusion is clear. The CDC committed a grievous error in ordering massive
amounts of Tamiflu for rapid distribution. Double-blind placebo controlled studies in respected
orthodox publications unequivocally state that Tamiflu does not work for H1N1. This is not an
isolated incident. A similar scenario unfolded in the UK and with wide media coverage. During
August 2009, across England, children taking Tamiflu fell deathly ill. Medical experts, outside
the government’s health ministry confirmed that Tamiflu is more harmful than good. But at the
end of a brief spark of media publicity, the government turned around, rejected the experts’
claims and continued to recommend Tamiflu in the advent of swine flu infection.47
There is no better place to begin a discussion on the effectiveness of the flu vaccine than to
introduce a statement on Canada’s Vaccination Risk Awareness Network (VRAN) website, a
community of physicians, researchers and vaccine scholars who report vaccines’ flawed
promises and pseudo-science. Among all vaccines, the flu vaccine is listed as “The Most Useless
Vaccine Of-All-Time Award.” CDC officials are even forced to confess that “influenza vaccines
are still among the least effective immunizing agents available, and this seems to be particularly
true for elderly recipients.”48 Dr. Anthony Morris is a distinguished virologist and a former Chief
Vaccine Office at the FDA. His views regarding the flu shot go much further. There is no
evidence that any influenza vaccine thus far developed is effective in preventing or mitigating
any attack of influenza,’ Dr. Morris states, “The producers of these vaccines know they are
worthless, but they go on selling them anyway.”49
Before every flu season, the Federal health agencies and HMOs commence campaigns
encouraging flu vaccination. More effort goes into advertizing, promoting, and deliberating state
policies for influenza than any other vaccination. Therefore we find individuals such as Dr.
Marie Griffin, a consultant for the large vaccine manufacturer Burroughs Welcome, leading
public relations campaigns to encourage flu vaccines on children. Who is Marie Griffin? Now an
Associate Professor of Preventative Medicine at Vanderbilt University and an independent
researcher ties to the Burroughs Welcome Fund, Dr. Griffin a principal researcher and author of
flawed studies to supposedly exonerate the pertussis vaccine from earlier scientific evidence
showing it caused neurological damage.50
A discussion on a vaccine’s effectiveness needs to first emphasize that vaccine theory has
basically remained unchanged since Dr. Edward Jenner first inoculated a person with a smallpox
virus at the end of the seventeenth century. The only essential knowledge a layperson requires to
understand vaccination is that a virus is intentionally introduced in the body in order to stimulate
the body’s immune system to produce its own antibodies to fend off the virus in the wild. Today,
there are other measuring factors being used to determine how much of an immune response is
being triggered and then other predictive calculations to determine whether or not the response
will be effective enough to ward off infection. Nevertheless, the entire basis for vaccination
relies solely on the introduction of a virus to the body. Another difference today is that vaccines
can have a live virus, an attenuated virus or an inactive virus. We are told that some of these
viruses are “killed”, but in fact, you can never fully kill a virus. Even a so called “killed virus”
still presents its genetic code in the body and it is well known throughout the community of
virologists that inactive or killed virus can reactivate. Live virus vaccines are little different than
that used by Jenner. Attenuated viruses are live viruses that have been weakened. This means
that parts of the virus have been more or less weakened.
When a virus is administered, the immune response becomes over-stimulated to produce
antibodies. One of the issues of vaccine medicine that has remained unexplored, an issue the provaccine establishment very likely wishes to ignore, is that whenever the body’s immune system
is over-stimulated—the ultimate mission of a vaccination in order to stimulate protection against
a virus—any other viruses, and bacterium, present in the body, which may or may not be
dormant, could enter a hyperactive state and subsequently pose a new threat in the body. This is
one reason why we so often hear people saying that after they have been vaccinated they feel
sick and that they repeatedly have bouts of viral infection.
The CDC recommendations for the launch of the new swine flu vaccine include children starting
at age six months. For years, seasonal flu vaccinations have been recommended to commence at
six months. All of the recently FDA-approved intramuscular swine flu vaccines comprise an
inactivated virus. So is there any evidence that inactivated viral H1NI and influenza vaccines are
effective and safe in very young children? After examining exhaustive studies, we have not
come across such evidence. Some of the most damning evidence was reported in two studies
performed by Dr. Tom Jefferson, head of the Vaccine Field group at the prestigious independent
Cochrane Database Group, published in The Lancet and the prestigious Cochrane Database
Systems Review. The first study was a systematic review of the effects of influenza vaccines in
healthy children.51 The other was a review of all the available published and unpublished safety
evidence available regarding the flu vaccine.52 The authors of the study had also contacted the
lead scientists or research groups for all the efficacy and safety trial studies under their review in
order to gain access to additional unpublished trial studies the corporations may possess. The
conclusions are shocking. The only safety study performed with an inactivated flu vaccine was
conducted in 1976. Thirty-three years ago! And that single study enrolled only 35 children aged
12-28 months. Every other subsequent inactivated flu vaccine study involving children enrolled
children 3 years or older.
Dr. Jefferson also told Reuters, “Immunization of very young children is not lent support by our
findings. We recorded no convincing evidence that vaccines can reduce mortality, [hospital]
admissions, serious complications and community transmission of influenza. In young children
below the age of 2, we could find no evidence that the vaccine was different from a placebo.”53
Both studies also investigated evidence of live flu vaccine safety in studies with children This is
especially relevant today because Medimmune’s approved nasal vaccine for the H1N1 swine flu
uses a live virus. As for live virus flu vaccines, no safety studies have been performed on
children younger than 22 months. Medical reporter for the Philadelphia Examiner, Deborah
Dupre, states, “Non-governmental organization, intellectually honest health professionals agree
that a person vaccinated with a novel A H1N1 live virus rather than inactive component viruses
is contagious.” National Vaccine Information Prevention founder and president Barbara Lo
Fisher concurs: “The live virus activated vaccine has the ability to spread flu.”54 Medimmune,
the sole manufacturer of the live flu nasal vaccine, repeatedly refused to give unpublished data to
Dr. Jefferson without executive clearance. The was also true for some vaccine makers working
with inactive virus.
The reviewers’ final assessment quotes from another group of vaccine investigators who share
similar views, “we are concerned by our findings of limited clinical trial evidence for inactivated
vaccines. In addition, the withholding of safety data for live attenuated vaccines makes it
impossible to present a complete evidence base of their safety. Although a frequent practice,
lack of reporting of non-significant outcomes raises the real possibility that our review may
present a biased picture.”55 In another article, Dr. Jefferson summaries his main points
concerning flu vaccines as follows:
Evidence from systematic reviews show that inactivated vaccines have little or no effect
on the effects measured
Most studies are of poor methodological quality and the impact of confounders is high
Little comparative evidence exists on the safety of these vaccines.56
Dr. Jefferson concludes, “We believe all unpublished trial safety data should be readily
accessible to both the regulatory bodies and the scientific community on request. Our evidence
gives rise to a concern that lack of access to unreported data prevents published data being put
into context and hinders full and independent review. This cannot be good for public confidence
in these vaccines.”57
Independent vaccine investigators and scientists, with no vested interest in the vaccine industrial
complex, and who wish to uphold the highest standards of scientific integrity, are faced with
great resistance and are basically hamstrung to procure necessary scientific and clinical trial data
from the vaccine industrial complex and their federal guardians in order for them to conduct their
research thoroughly. Federal agencies do not regulate what a corporation does or does not do
with all of its clinical data on vaccine efficacy and safety. All that is required from vaccine
makers is the necessary documentation required for FDA submission in order for approval and
registration. All other data is a sealed proprietary vault off-limits to the rest the world’s scientific
community unless such wishes for access be sanctioned by the corporations. This in itself is a
violation of the highest ethics of true medical science, which by definition should be a quest for
discovering and confirming medical facts and by sharing information publicly so scientists can
further their knowledge to find the best solutions for tackling our health problems and solutions
for them.
Australian scientist and vaccine expert, Dr. Viera Scheibner, has investigated the criteria vaccine
makers use to conduct human trials to determine a vaccine’s safety and the means by which they
determine their results. Vaccine makers use an “exclusion criteria.” If the same data were
calculated under a different set of guidelines, particularly guidelines requiring double blind
studies and true placebos, the results could be dramatically different. As an example, Dr.
Scheibner shows how children in a MMR vaccine trial developed measles after injection were
then able to be excluded from the final calculations based upon the company’s safety criteria.
Unfortunately, her investigations show that this practice is “unashamedly” repeated time and
time again by vaccine makers during clinical trials.
One excellent example is measles. Measles would have very likely disappeared on its own due to
better sanitation, nutrition and cleaner resources. By the time the measles vaccine was first
launched for mass immunization, measles infection had already decreased 90 percent. Opponents
of the measles vaccine, who have shown that vaccination actually perpetuates the virus, point out
studies performed among the Amish people living in small communities in the United States.
There were no reports of measles among the Amish between 1970 to 1987. Then on December 5,
1987, there was a large outbreak of measles, at the time that the pro-vaccine establishment was
claiming victory over this infectious disease and contributing it to vaccination. Dr. Scheibner has
studied this phenomenon extensively, and concludes that it was the vaccine that kept measles
“Are vaccines effective? [In my opinion they are] Definitely not. They are only effective
in creating harm, damage to organs in the body. They cause all those modern ills of
humanity, all those autoimmune degenerative diseases…. And it is all published and
refereed in medical journals. So the evidence is right from the horse’s mouth.”
A scientific study in review for peer-reviewed publication was reported on CTV, Canada’s
largest private television network, on September 23, 2009. The study, conducted in three
Canadian provinces—British Columbia, Ontario and Quebec—by Toronto’s Mount Sinai
Hospital, raises serious concerns over the potential efficacy of the new H1N1 flu vaccine based
upon new data showing that a person vaccinated with last year’s seasonal vaccine are more
susceptible to contracting the H1N1 virus. Because of the critical questions being raised about
the lack of safety trials that have been undertaken for the H1N1 vaccine, the researchers
considered their findings an urgent warning before the vaccine is launched on the public.
Moreover, there remains uncertainty over the concurrence of both H1N1 and the regular seasonal
flu this Autumn. Canadian officials are even now discussing the possible need for small children
to receive four flu vaccinations to cover each stain.59
The Toronto study raises a fundamental question that has not been addressed previously. First,
to date, no clinical trials have been conducted to determine how the swine flu vaccine will
interact with other flu shots. Second, there are no studies to ascertain whether or not the swine
flu vaccine will make recipients more susceptible to infection from other flu strains. What the
study does assure us is that influenza vaccines are interfering with the body’s natural immunity.
In fact this study is showing a causal relationship between the influenza vaccination given to a
depressed immune system and the increase likelihood that the individual will contract another
wild flu virus.
The vaccine industrial complex frequently attempts to inflate vaccines’ benefits by tacking on
other medical indications it will protect for. Although there is strong evidence that vaccinations
may contribute to the ever-increasing rise in ear infections that countless parents experience
repeatedly with their small children, vaccine makers want to convince us that flu vaccines may
prevent ear infections. Buried in unpublished papers is a study presented to the 2002 meeting of
the Pediatric Academic Sciences involving 793 children aged 6 to 14 months. The study found
that there was no decrease in ear infections, doctor visits, ER visits, antibiotic prescriptions or
missed daycare days between those children who received the vaccine and those who received
placebo (meaning the vaccine without the viral component). However, every child in the study,
had doctors’ visits throughout the season. While this might dispel the vaccine industry’s claims
that the flu virus might cause ear infections, there is an obvious flaw. All children in the study
received the same non-viral ingredients—adjuvants, thimerosal, and other chemicals—which
contributed the children’s infections and physician visits.60
Over the decades I have interviewed many of the world’s most knowledgeable vaccine scientists,
researchers and physicians working with children who have been victims of vaccination. Among
the questions I routinely ask, is whether or not there is any evidence that vaccine makers conduct
randomized double-blind placebo studies to determine efficacy and safety. Throughout true
science, this protocol has served as the gold standard. And never have I ever heard anyone in the
entire medical community, nor any of my own research, say they found evidence for randomized
double-blind placebo studies ever being conducted in vaccine trials.
The use of placebos most commonly used in vaccination trials is exceedingly important. In
standard scientific methodology a placebo should be a very inert substance, such as water or a
sugar, in order to accurately determine the tested substance’s effects on human biology.
According to world vaccine expert Dr. Viera Scheibner, vaccine trials do not employ an inert
placebo. Instead, what is used as a placebo is “the vaccine with all the adjuvants and
preservatives, certainly not inert substances, minus those viruses and bacteria… That is why
when they compare the trial children who were given the lot and those who were given placebo,
they have the same rate of reaction.”61 These means that almost all vaccine efficacy and safety
trials using a non-inert placebo are based on scientifically flawed design from the start. It is
therefore evident that flawed methodology will inevitably result in flawed data. Yet that is the
guiding principle the vaccine industrial complex relies upon, and our federal health
establishment is all too ready to give a nod of approval and allow it to continue.
During the 1980s, Japan had mandatory flu vaccination for school children in school. Two large
scale studies that enrolled children from four cities with vaccination rates between 1 and 90
percent discovered there was no difference in the incidences of flu infection. As a result, in 1987,
Japanese health authorities ruled that flu vaccination was ineffective and was no more than a
serious liability if it was to continue. Therefore, the mandatory policy was quickly overturned.
By 1989, the numbers of Japanese taking the flu vaccine dropped to 20 percent. A follow up
study at that time found that there was statistically insignificant change in influenza infection
rates compared to when the vaccine was mandatory.62
The vaccine industrial complex makes the claim that flu vaccination will reduce asthmatic
attacks brought on by flu infection among those children who are susceptible to them. A study by
Dr. Herman Bueving at the Department of Family Practice at Erasmus University Medical
Center in Rotterdam, Netherlands, conducted one of the few randomized, double-blind placebo
studies found in vaccine literature. The two-year study enrolled 696 asthmatic children, half
vaccinated and the rest administered a placebo. The study found there was no difference between
the number and severity of asthmatic attacks between the two groups. This study gives further
support in flu vaccination’s ineffectiveness.63
Vaccines are even shown to be less effective among the elderly, people over 65 years of age.
Nevertheless, this age group is one of the primary targets for the swine flu vaccine, as it has been
with other flu vaccines each season. Even the CDC acknowledges this fact. There have been
many studies conducting in nursing homes to determine how effective flu vaccines are in
preventing infection. Average effectiveness, meaning only to stimulate an adequate immune
response, are in the low to mid twenty percent range (21-27 percent). Another set of four studies
indicate the flu vaccine was 0, 2, 8 and 9 percent effective.64 Yet despite some of these dismal
results, the CDC still wishes us to believe that vaccinating elderly citizens is “50-60% effective
in preventing hospitalization and pneumonia and 80% effective in preventing death.65
Government health projections confirm, and the CDC has had to acknowledge this, that elderly
people, with or without the flu shot, show less than a one percent rate of being hospitalized for
pneumonia and influenza. That means that 99 percent of elderly people manage to weather the
In recent years we are now seeing supposed scientific studies emerging that are nothing more
than commercials, public relation spectacles, to promote vaccination’s efficacy. Such studies
either remain unpublished or are reinvented for publication well after the fact. Their sole purpose
is to confuse a negative with a positive twist. They are no more than promotional spins designed
by the vaccine industrial complex, and their cohorts in other private health sectors, to support
their financial interests. In turn, they are used as a means to influence the nation’s health policy
makers, relieve any doubts concerning their vaccine’s efficacy and safety. The nation’s health
agencies then rely on these fabrications to convince the larger public healthcare community and
citizens about the importance of being vaccinated.
Edward Yazbak, MD, an independent vaccine researcher and an expert in autoimmune regressive
autism injury, did a thorough review of one such study entitled “Effectiveness of the 2003-2004
Influenza Vaccine Among Children 6 Months to 8 Years of Age, with 1 vs. 2 Doses”. After his
analysis of the study’s data, he voted it “Most Creative Title of the Year.” The completely flawed
study was meant to serve two fundamental purposes. First, to show flu vaccine’s efficacy, and
second, to send a message that one dose was inadequate and two inoculations should be
recommended in the vaccine schedule. Although the lead researcher Dr. Debra Ritzwoller and
her colleagues claim in the document that they had no conflict of interest, they were employees
of a large HMO, Kaiser Permanente. Dr. Ritzwoller is an economist specializing in health
services. Two other researchers worked for the National Immunization Program. The study was
eventually published more than a year later in the November 2005 issue of Pediatrics. In the
document’s footnote, the study was first presented to the July 2004 meeting of the Advisory
Committee on Immunization Practices (ACIP), an entity under the CDC. Therefore, it never
went through peer-review before presentation to our nation’s highest advisory group making the
crucial decisions on vaccine policy recommendations.
The study enrolled 29,726 children in the Denver area, 5,142 who were 6 to 23 months old.
While this figure may appear impressive, Dr. Yazbak makes the acute observation that “figures
in the thousands or millions in medical writings always raise a red flag for me” and in almost all
cases with studies of this magnitude, they represent a “smokescreen.” Studies of this size simply
cannot execute sound scientific inquiry nor perform proper due diligence to arrive at any
conclusive information. He also noted a peculiar timing between when the study was conducted
and an earlier Colorado study by the same group of researchers, which remains unpublished, and
reported to the CDC’s Mortality and Morbidity Weekly Report (MMWR). Both were
sequentially and perfectly timed between the new recommendations to vaccinate children in the
6-23 month range and the beginning of the 2004 flu season.
As a result of Ritzwoller and her team’s data, the ACIP declared, vaccination of children 6 to 23
months of age decreased hospitalization rates. However, the study never tracked any hospital
admissions of the enrolled children. Later, a separate medical investigator queried the study’s
lead author, Dr. Ritzwoller, on whether the flu vaccine caused any adverse reactions. By her own
admission Ritzwoller stated there were none, but that “hospital admissions were not tracked, and
the parents were not interviewed.”67
In a curious twist of fate, corporations, far removed from drug and vaccine development, but also
obligated to test and market their own products, conduct studies that contradict the dogma of the
pharmaceutical industrial complex. Procter and Gamble have conducted numerous studies on
their common household products such as soap and liquid detergents. One such study was a
randomized, placebo study of 611 hundred households, in 36 separate neighborhoods, in
Karachi, Pakistan to determine whether frequent use of a common hand soap, an antibacterial
(promotional) soap and a placebo soap would reduce the rate of lung infections due to
pneumonia among children. Trainers visited each family weekly to educate and teach proper
hand washing use and personal hygiene. When we review below the FDA’s and CDC’s flawed
methodology for promulgating their myth that 36,000 Americans die annually from flu
infections, we will see that over 90 percent of these mortalities are a result of pneumonia
infections, not the influenza.
Proctor and Gambles results are quite startling with a fifty percent lower incidence of pneumonia
infections among children under five with the plain and antibacterial soaps compared to placebo.
There was also a 53 percent reduction in diarrhea and a 34 percent decrease in incidences of
impetigo. While this may appear to be an irrelevant example, it is not off the mark. Dr. Ton
Jefferson, head of the Cochrane Vaccine Field at the Cochrane Database Group in Rome, who
has performed some of the most extensive analysis in the efficacy of flu vaccination during the
course of the past 37 years, arrived at the conclusion, “People should ask whether it’s worth
investing these trillions of dollars and euros in these vaccines.. What you see is that marketing
rules the response to influenza and scientific evidence comes fourth or fifth. The best strategy to
prevent illness is to wash your hands.”68 69 And if you are among those who would hold Dr.
Jefferson suspect, then even the FDA’s and CDC’s 1999 directive to manufacturers to remove
mercury from vaccines recommends that the safest and most effective way to prevent flu
infections is frequent hand washing and a healthy lifestyle.70
An equally disturbing scenario unfolds about efficacy and safety trials conducted with pregnant
women. In 2001, the CDC started to recommend the flu vaccine to all pregnant women. Eight
years later, pregnant women are now being targeted as a priority group for the H1N1 vaccine.
Nevertheless the vaccine is a Category C drug; which means there are no adequate safety studies
after two studies published in 1973 and 1979 to determine whether flu vaccination adversely
affects pregnant mothers and their fetuses.71 What remains utterly amazing is that many serious
questions about live flu vaccines remain unanswered. Most shocking is the uncertainty as to
whether the vaccine itself, having been administered nasally, might not transmit contagious
infection in others. Worse is the lack of studies to determine the possibility of a serious
immunological threat when an attenuated virus, which replicates more rapidly, is administered to
individuals with compromised immune systems.
An important Dutch study was conducted in a large home for the elderly. In spite of two thirds of
them having been vaccinated, the flu infected 49% of them, including bacterial and pneumonia
infections, and 10% died. The critical observation found in the study was that 50% of those
vaccinated got the disease whereas 48% of non-vaccinated people were infected. The results of
this study clearly show that vaccination was useless.72
Dr. Sherri Tenpenny reviewed The Cochrane Database of Systematic Reviews to analyze the
efficacy of flu vaccines. Below is a summary of her analysis.
In a review of more than 51 studies involving over 294,000 children, there was “no
evidence that injecting children 6-24 months of age with a flu shot was any more
effective than placebo.
In children over 2 years of age, flu vaccine effectiveness was 33 percent of the time
preventing flu.
In children with asthma, inactivated flu vaccine did not prevent influenza related
hospitalizations in children. The database shows that children who received the flu
vaccine were at a higher risk of hospitalization than children who did not receive the
vaccine. In a separate study involving 400 children with asthma receiving a flu vaccine
and 400 who were not immunized, there was no difference in the number of clinic and
emergency room visits and hospitalizations between the two groups.73
In 64 studies involving 66,000 adults, “Vaccination of healthy adults only reduced risk of
influenza by 6 percent and reduced the number of missed work days by less than one day.
There was change in the number of hospitalizations compared to the non-vaccinated.
In 64 studies during 98 separate flu seasons involving elderly adults residing in nursing
homes, flu vaccinations were non-significant for preventing infection.74
When we hear official reports released by the FDA and CDC, transmitted throughout major
corporate media and publications, that a particular vaccine is safe, we should immediately perk
to attention, raise a red flag, and muster rational suspicion. One of the most important questions
is, what kind of studies were performed to determine that any vaccine is essentially safe,
especially in infants, small children, pregnant mothers, the elderly, and those with compromised
immune system due to pre-existing illnesses prior to vaccination?
Vaccine manufacturers, according to the statutes of the FDA’s Public Health Service Act are
required to show that a vaccine complies with three criteria before approval and launch: safety,
purity and potency. There is no requirement before FDA approval and licensing of a vaccine
that the vaccine undergo any independent studies, by researchers with no vested financial
interests, to validate a vaccine applications scientific claims. Rather, the entire approval process
is nothing more than a good-faith relationship between the manufacturer and the FDA and its
vaccine advisory departments and committees.
The FDA defines a vaccine’s effectiveness in terms of its potency to trigger a targeted immune
response sufficient enough to produce antibodies against the particular virus strain. The FDA
guidelines require vaccine makers to conduct placebo-controlled clinical efficacy studies on
healthy adults, who are free of at-risk complications. Clinical trials with at-risk individuals,
including infants, small children, pregnant mothers and people over 65 of age are not mandatory
for regulatory approval. How do the vaccine makers determine whether or not a vaccine is safe
to these other at-risk groups before FDA approval? Well, they don’t except by predicting past
incidences of vaccine effectiveness and safety. The vaccine industrial complex is under no
federal obligation to give sound scientific evidence that their vaccines are safe in anyone except
health adults.
What is quite extraordinary in the FDA’s Center for Biologics Evaluation and Research’s
document, “Guidance for Industry: Clinical Data Needed to Support the Licensure of Seasonal
Inactivated Influenza Vaccines”, is the great amount of leeway permitted vaccine manufacturers
to prove a vaccine’s safety. For example, “the protocol should include a clinic visit or telephone
contact at least six months post-vaccination to ascertain serious adverse events.” Or, “we
recommend that you assess the safety of your investigational vaccine in several thousand
subjects.” Or, “we assume that approval for use in the adult population, including the geriatric
population, would be sought with the initial application.” More seriously is this allowance given
to a vaccine manufacturer, “For vaccines using novel manufacturing processes and/or adjuvants,
laboratory safety tests including hematologic and clinical chemistry evaluations, may be needed
pre- and post-vaccination in the first clinical studies.” (All italics are ours to clearly identify
word choice in the official CDC document).
Curiously, we never hear an all-embracing confirmation from federal health agencies, which
oversea the data of vaccine safety before a vaccine’s release to physicians, hospitals and
healthcare facilities, that ALL vaccines are collectively safe. Neither will you find such
pronouncements made in any published literature. Instead, we hear only of individual vaccines.
How are we suppose to interpret this?
One of the CDC’s and vaccine industrial complex’s secret weapons is the Vaccine Safety
Datalink. No independent scientist or investigator has access to its contents without being
anointed by of federal health officials who stand at its guard. How is this network of proprietary
data used by its government overseers?
During the 2006-2007 flu season, a perfectly timed article appeared in the October 25, 2006,
issue of the Journal of the American Medical Association entitled “Safety of Trivalent
Inactivated Vaccine in Children 6 to 23 Months Old.”75 The study was conducted by
investigators from an HMO and four co-authors from the CDC. According to the investigations
by the independent vaccine expert, Dr. Edward Yazbak, the HMO “has had a close relationship
with the CDC for years and its members have been enrolled in multiple pre-licensure vaccine
trials.” Further, the publication of the article was perfectly timed for a national PR launch since
the government health agencies had already purchased their stocks of flu vaccine from the
vaccine industrial complex and needed to unload them. The study also relied on the data in the
Vaccine Safety Link and we are told it analyzed “significant medically attended events in all the
databank’s 6 to 23 month old children vaccinated between January 1991 and May
2003—supposed numbering 45,356 children and a total of 69,359 vaccinations.76
The conclusions of the study state, “In the largest population study to date of the safety of
trivalent inactivated influenza vaccine in young children, there were very few medically attended
events, none of which were serious, significantly associated with the vaccine. This study
provides additional evidence supporting the safety of universally immunizing all children 6 to 23
months old with influenza vaccine.”77
What is most disturbing about this study, which JAMA should have rejected for publication, is
that it relies on safety data unavailable to independent research and analyses. Therefore, it is a
flagrant violation of medical science that can serve no other purpose than the financial goals of
vaccine makers, the insurance industry and their federal health colleagues.
Three days after the JAMA article, the October 28, 2006 issue of the British Medical Journal had
a piece by its editor Fiona Godlee, who commented on Dr. Tom Jefferson’s article attacking the
UK’s vaccine policy—which consistently mirrors the US—in the same issue. Godlee wrote,
“As if to prove the point, we publish this week a broadside (based on a systematic review of the
literature) about the lack of evidence for influenza vaccine. Why, asks Tom Jefferson (p. 912), is
there such a gap between evidence and policy? Governments go to great lengths to promote and
provide the vaccine. But there is almost no valid evidence that it does any good. Jefferson puts
the gap down to our desire to do something, combined with”optimism bias”—an unwarranted
belief in the value of interventions. Would randomized trials be unethical? No, says Jefferson,
they are the only ethical response to the possible waste of resources on ineffective or only
partially effective care. The problem is that the UK has no transparent process for evaluating the
effectiveness or cost effectiveness of vaccines.”78
More recent, a cohort study of 263 children, from 6 to 18 months who were confirmed positive
with influenza, evaluated to determine the trivalent flu vaccine’s effectiveness. The Mayo Clinic
in Rochester, Minnesota study was presented at the 105th International Conference of the
American Thoracic Society and found that children who had received the vaccine had a three
times risk of hospitalization compared to children who were not vaccinated.79 An earlier study of
800 children suffering with asthma found that those who received a flu vaccine had a significant
increased risk of asthma-related doctor and emergency room visits.80 These results were later
reinforced by another study showing that the attenuated virus flu vaccine, FluMist, contributed to
a triple risk of children with asthma being hospitalized.81
As of 2007, the CDC’s recommended Immunization Schedule for physicians and pediatricians
lists 9 separate vaccinations to be given to infants before completion of their second month, an
additional 27 separate vaccinations to be injected in the child by 18 months of age. The total
number of vaccinations a person should receive by 15 years of age is 64 (not including the HPV
vaccine that has since been added to young girls entering their teens). Other vaccines are now in
the R&D pipeline for diseases such as chlamydia, herpes simplex type 2, hepatitis C, West Nile
virus, Epstein-Barr virus, and others.82 The World Health Organization notes that intensive
efforts also are under way to develop effective vaccines for malaria, tuberculosis, dengue, and
other diseases.83 A fundamental question being ignored is when is there enough. Furthermore,
there is every indication that the number of mandated vaccinations will continue to rise as
vaccine manufacturers continue to research and develop vaccines for other infections and
The chart below provides a breakdown of recommended vaccine schedule.
Centers of Disease Control’s Immunization Schedule for 20071
Number Shots
Hepatitis B
1 vaccine
1-2 Months
Hepatitis B
1 vaccine
2 Months
DPT, Polio, Hib, PCV,
7 vaccines
4 Months
2nd shots of DPT, Polio, Hib,
PCV, Rotavirus
7 vaccines
6 Months
3rd shots of DPT, Hib, PCV,
6 vaccines
Figures reproduced from O’Shea, Tim. The Sanctity of Blood. 11th Edition, 2007 p 50-51
Number Shots
6 Months to 18 Months
Influenza (yearly), Hepatitis
B, Polio
3 vaccines
12-15 Months
MMR, Hib, PCV, Varicella
6 vaccines
12-23 Months
Hepatitis A (twice)
2 vaccines
15-18 Months
3 vaccines
TOTAL (from birth to 18 months)
36 vaccines
4-6 Years
DPT, MMR, Polio, Varicella
8 vaccines
11-12 Years
Tetanus/Diphtheria, HPV (3
doses), MCV4
6 vaccines
15 Years
1 vaccine
2-15 Years
Influenza (yearly)
14 vaccines
TOTAL (from birth to 15 years of age)
64 vaccines
It has now become a routine practice for physicians to administer multiple vaccine injections in
infants and toddlers during a single visit. A review of the above chart numbers will show,
especially among children, many vaccines can be given during a single month. Is there any
evidence that the combination of all these vaccinations trigger disease and neurological
malfunction? No, because no such studies have been performed. In fact, there is no regulatory
requirement placed upon vaccine manufacturers to determine whether their vaccines are safe in
the presence of other vaccines or when multiple vaccines are administered together during a
single doctor’s visit.
In addition, there are numerous scientific reports and case studies to support the position that
vaccine ingredients, particularly the adjuvants and preservatives used in the flu vaccines, are far
more dangerous and pose a much higher health risk than the reported incidences of H1N1
infection. Patti White was a school nurse who testified before the House Government Reform
Committee in 1999. In her statement she said, “Vaccines are supposed to be making us healthier;
however, in twenty-five years of nursing I have never seen so many damaged, sick kids.
Something very, very wrong is happening to our children.”84
A major concern among vaccine critics and many medical and vaccine experts is that the new
swine vaccine is being launched before scientifically sound human trials are conducted to
determine efficacy and safety. Swine flu vaccines are being fast-tracked in order to have it ready
for October. Results from human trials to test the new H1N1 flu vaccine are starting to be
reported. In terms of the corporate articles being published, we might believe these results are
promising. On closer inspection of a review of the methodology, number of trial participants, the
particular age and health-risk groups selected, trial length and follow up, it is erroneous to
conclude that these studies were performed with scientific rigor and integrity.
CSL Ltd is an Australian vaccine maker whose novel influenza A (H1N1) vaccine was recently
approved by the FDA. The company’s immunological and safety trials included only 240
subjects. This is far less than would be expected of vaccine because more serious and fatal
adverse effects, unless in more infrequent circumstances such as with the polio vaccine, appear
as one in thousands. All human subjects were healthy adults, meaning there were no known preconditions that would suppose an impaired immune system. CSL has not tested its vaccine on
any children from 6 months and older, nor on pregnant women and the elderly. The trial lasted
only 21 days and there is no indication of long term follow-up. Forty-five percent of the subjects
reported systemic events such as headaches, malaise and myalgia, however, CSL decided to
consider only 30.4 percent as vaccine related—for reasons that are unexplainable! More
interesting, “three subjects had influenza-like illness, one of whom tested positive for 2009
H1N1 on day 8 after vaccination.”85
In 2008, the multinational vaccine maker Novartis was forced to withdraw its Aflunov vaccine,
which contained the MS59 squalene adjuvant, for avian bird flu when the European Medicines
Agency (EMEA) found the clinical trials did not meet “good clinical practice” and the results
were unreliable for approving the vaccine. In addition, the sample of participants was too few to
assure the vaccine’s safety.86 What is particularly important in this one example is that Novartis’
Aflunov was a mock up vaccine being developed for what the WHO and other health
organizations predicted to be a forthcoming global avian flu outbreak.
If this report is used as a recent precedent for the way Novartis conducts vaccine trials, how
might we suppose it conducted its trials for the H1N1 swine flu? A report from MedPage Today
has confirmed that Novartis’ trials for the H1N1 vaccine, called Celtura, are equally suspect,
however, the EMEA has given it a green light. According to the report, Novartis’ immuneefficacy and safety human trial enrolled only 100 healthy people at the University of Leicester in
the UK. The study was sponsored by Novartis, and the lead scientist conducting the trials, Dr.
Iain Stephenson is on record for receiving funds from Novartis. Again, the vaccine includes the
MF59 adjuvant and was determined “safe” during the two week trial.87
The British Herald reports that GlaxoSmithKline, one of the swine flu manufacturers that will be
using the squalene adjuvant, is conducting a two-inoculation trial with only 128 healthy adults
Dr. Kathleen Neuzil, in her article in the September 10, 2009 issue of the New England Journal
of Medicine, reviewed the swine flu vaccine trials of several of these companies and warned,
“The immune responses in children are unknown…. Immunogenicity data in young children are
critical to guide policy decisions.”88 The question can be aimed at the WHO whether or not Dr.
Margaret Chan, the WHO’s Director General, realizes that giving adjuvanted vaccines where
there is no discernable safety data amounts to a biological experiment that violates national and
international law?
Pregnant women are now being listed as a high priority for swine flu inoculation. Yet the product
inserts so far from the pack inserts published by the vaccine manufacturers state the disclaimer:
“Animal reproduction studies have not been conducted with influenza virus vaccine. It is also not
known whether influenza virus vaccine can cause fetal harm when administered to a pregnant
woman.”89 By their own admission, the vaccine industrial complex has not even performed
clinical studies on pregnant animals, let alone pregnant human women!
The Canadian Health Ministry has confirmed that there is no data on the use of adjuvanted swine
flu vaccine in pregnant women that would warrant administering it to this category of
recipients.90 In fact flu vaccines, as with all other vaccines have not been fully tested to
determine teratogenic effects, the dangers vaccines have on the fetus. Unlike the US, Canada is
more wary about the medical evidence showing adjuvants have a high adverse threat to pregnant
women and the fetus. This conclusion was drawn earlier by the WHO. Dr. Marie-Paule Kieny,
head of the WHO’s vaccine research department, stated, “Does that mean that it (adjuvanted
vaccine) will be unsafe? No. It means that there is no hard evidence that it will be safe.”91
The pro-vaccination community abides by the prevailing myth that the placenta serves as a kind
of barrier or wall that protects the fetus from toxic chemicals, metals and contaminants and
pathogens in the pregnant mother. This belief has been destroyed by one of the most important
discoveries in recent years. The Environmental Working Group, an independent non-profit
organization that conducts laboratory research on environmental toxins. Upon testing umbilical
cord blood for over 200 of some of the most dangerous chemicals found in our environment, the
researchers came to the startling results that on average approximately three quarters of them
were present in umbilical cord blood. The urgent importance of this discovery is that the placenta
does not serve as a reliable filter and hazardous chemicals, which would include those used in
vaccines, will make their way to the developing fetus and can contribute to untold damage and
genetic alterations leading to long-term diseases as the child grows up. This in and of itself
should force us to pause and reconsider the serious side effects being inflicted on unborn
children from vaccine ingredients such as ethylmercury (thimerosal), aluminum hydroxide,
formaldehyde, polysorbate, MSG and others. A 1999 article in the American Journal of
Epidemiology stated, “the greatest susceptibility to methylmercury neurotoxicity occurs during
late gestation.” Although this particular study investigated the adverse effects of methylmercury
during pregnancy, given the strong evidence of neurotoxicity in children who received
thimerosal-laced vaccines, the same can therefore be said concerning ethylmercury.
Although at the time of composing this document, we have been unable to identify specific FDA
and/or EMEA approval of cancerous cell lines in the preparation of the flu vaccine, a secondary
source confirms cancer cells are currently being used as vaccine cell substrates. Dr. Wolfgang
Wodarg, the chairman of the Health Committee of the German Parliament and the European
Council and a specialist in pulmonary medicine, warned that the nutrient solution used in
Novartis’s developing an H1N1 vaccine, which has now been approved by the FDA, includes
known animal cancer cells (italics added) and, therefore, poses a serious health risk.92
Johannes Lower, president of the Paul Erlich Institute predicts that the death rate in Germany in
the event of mass vaccination, using the currently approved vaccines for Europe, would be
60,000 casualties. Calculating Dr. Lower’s figure for the American public, we would be looking
at over 307,000 deaths, nine-fold higher than the annual influenza mortality rate claimed by the
CDC during a normal flu season. In such an instance, it is clear that the risks of vaccination far
outweigh the benefits based on American health agencies’ calculations.
Among the different more serious and life-threatening adverse effects that have been associated
with the flu vaccine, and found in the scientific literature are:
Guillane-Barre Syndrome (discussed below)
Polyneuritis and related conditions such as polyradiculitis and polyganglioradiculitis93
Parsonage Turner Syndrome94
Meningeal infection, separate or as part of Guillain Barre Syndrome.95
Multiple sclerosis97
Intense headaches suggestive or meningeal or brain irritation98
Aphasia (loss of speech)100
Sexual impotence102
Impeded hearing103
Eye disorders including proptosis, retina oedema, diplopia, nystagmus, eye muscle
Angor pectoris105
Anaphylactic reactions106
During the swine flu scare of 1976, President Gerald Ford approved a rapid mobilization of mass
vaccination upon American population that resulted in 40 million citizens unnecessarily
vaccinated. The predicted epidemic never arrived, and the vaccine proved to be catastrophic. In
fact, the entire incident was a debacle based on bad vaccine science and predictive methodlogy.
There were approximately 500 known cases of and 25 known deaths from Guillain-Barre
Syndrome (GBS). Actual known deaths due to the H1N1 virus that same year were one. A
retrospective study conducted by US health agencies discovered the vaccine had increased GBS
risk eight-fold. The government was forced to pay out millions of dollars to injured vaccine
GBS is an autoimmune disorder affecting the peripheral nervous system, associated with an
acute infectious mechanism. It exhibits paralytic symptoms spreading from the legs to the upper
limbs followed by complete loss of deep tendon reflexes. Due to GBS’s paralytic symptoms,
severe pulmonary complications and autonomic nervous system dysfunction can result in
The evidence for an association between the flu vaccine and GBS did not first appear during the
1976 swine flu vaccine debacle. In 1958, there were two reports showing cases of severe
paralytic nervous system disorders occurring after vaccination with the flu virus. There were
also increased risks noted for GBS during the flu seasons between 1992 and 1994.110
Although the H1N1 vaccine being fast tracked and launched on world nations is different in
some ways from the vaccine distributed in 1976, there are also many similarities. For this reason,
government health officials have been alerted of a strong possibility that cases of GBS will result
from the new vaccine this year. On August 15, 2009 the British Daily Mail released a leaked
letter from the British Health Protection Agency addressed to 600 British neurologists with the
warning that they should be on alert for incidences of GBS among citizens inoculated with the
H1N1 vaccine. The letter originated from the highest level of the UK’s health ministry, Dr.
Elizabeth Miller, head of the HPA’s Immunization Department. One senior British neurologist in
response to the warning said, “I would not have the swine flu jab because of the GBS risk.”111
This begs the question of the lack of transparency between government health officials and the
citizenry, and between the pharmaceutical vaccine makers and the professional medical
associations who keep practicing physicians and clinicians educated with the latest findings and
warnings about the drugs and vaccines they administer daily to their patient cliental. A statement
by a Conservative member of the UK’s Parliament’s Health sector, Mike Penning, concerning
the government’s secrecy regarding the swine flu vaccine is apropos for leveling against our own
White House health leaders. He stated, “The last thing we want is secret letters handed around
experts within the NHS (National Health Service). Our job is to make sure that the public knows
what’s going on. Why is the government not being open about this? It’s also very worrying if
doctors, who will be administering the vaccine, aren’t being warned.”112
Two weeks later the CDC publicly followed suit. As reported, “The US Centers for Disease
Control and Prevention and the American Academy of Neurology have asked all neurologists to
report new cases of Guillain-Barre in people who get vaccines this fall and winter to the Food
and Drug Administration’s Vaccine Adverse Event Reporting System.”113
These pronouncements are clear indicators of a serious concern burdening government health
officials as they continue to push forth an experimental flu vaccine that has not been approved by
the more stringent regulations of rigorous clinical trials to determine vaccine safety and
effectiveness. They have a great deal to worry about if warnings by Dr. J. Seal of the National
Institute of Allergy and Infectious Diseases is accurate: “Any and all flu vaccines are capable of
causing Guillain-Barre.”114
It is uncertain whether or not the new swine flu vaccines approved in the US will contain the
adjuvant squalene, a natural organic compound and precursor to the family of steroids. So far
the ingredient information published by manufacturers does not list it. Health experts at the
WHO have been calling for the inclusion of an adjuvant in order to increase the availability of
vaccine lots throughout the world. Novartis has also publicly concluded the same (Novartis is the
primary provider of MS59 squalene-laced adjuvant in vaccines). In the absence of an adjuvant,
more viral antigen is required and, according to reports, vaccine manufacturers are unable to
meet the demand from the global community of nations. Adjuvants, such as squalene and
aluminum compounds, increase a vaccine’s potency when there is not a close match between the
virus contained in the vaccine and the projected strain of the virus being targeted in the event of a
future outbreak.
This is always the case for influenza. Unlike other infectious pathogens, there is a great deal of
guess work among flu vaccine makers to determine what flu vaccine they need to develop for
any given flu season. The mathematical models used to make their decisions are based on the
epidemiological and demographic records from the previous flu outbreaks. However, there is no
way an accurate prediction can be made as to whether the viral antigen contained in flu vaccine
will be an identical or a close match to the actual flu that appears. It is strictly a predictive,
subjective calculation. Dr. Michael Decker from the flu vaccine maker Aventis admits, “By the
time you know what’s the right strain, you can’t do anything about it.115 This is even
acknowledged by the CDC,
“However in some years when vaccine and circulating strains were not-well matched, no
vaccine effectiveness may be able to be demonstrated. It is not possible in advance of the
influenza season to predict how well the vaccine and circulating strains will be matched,
and how that may affect vaccine effectiveness.”116
If the selected vaccine antigen and actual virus is not a close match, the vaccine will be far less
effective in creating sufficient antibodies to induce immunity. In order to compensate for this
problem, an adjuvant is added to boost the antigen’s effectiveness. So far, reports from the
H1N1 vaccine manufacturers are stating that the new flu vaccine antigens show a close matching
and therefore US health officials, and vaccine makers, are saying vaccines can be released
without an adjuvant.117 Of course, there is absolutely no way to confirm their claim until cases of
the H1N1 strain begin to appear. Until then, it is all guesswork.
The flu virus is more susceptible to gene amplification than other viral and bacterial pathogens.
Gene amplification is a cellular process by which a gene produces multiple copies of itself in
order to amplify and preserve the phenotype the gene confers to the cell. Cancer cells, for
example, undergo rapid gene amplification, which contributes to their greater drug resistance.
When people are very sick from a flu infection, or when large numbers of individuals are
infected, the flu virus’ gene amplification increases dramatically. And with rising amplification,
there are faster rates of viral mutation, thereby developing in new strains.118
In the US, squalene has not been approved by the FDA for vaccines. Although the FDA has
refused to take a strong stance on the serious, proven risks of squalene, the FDA’s chief scientist
Dr. Jesse Goodman states, the FDA’s rationale for disallowing the adjuvant is because “there’s
just more uncertainty” while still claiming “there is not a known, specific safety danger or issue
regarding them.”119 Due to recent acts and provisions passed during the Bush Administration,
squalene could be potentially used in compliance with an emergency authorization, that enables
unapproved drug ingredients to be permitted and bypass the standard regulatory approval
The most recent flu vaccines are either intramuscuilar or intranasal.
The intramuscular vaccine is preparted from influenza viruses propogated in embryonated
chicken eggs and centrifugated with detergent. Other components used in the preparation of the
vaccine include: octoxynol-, a-tocopheryl hydrogen succinate, polysorbate 80. The product
literature states that thimerosal is used during the early manufacturing process and then removed
to trace amount levels. Each dose may contain hydrocortisone, gentamicin sulfate, ovalbumin,
formaldehyde, and sodium deoxycholate.120
The intranasal vaccine administered to children 2 years and up is made from a live attenuated
influenza virus for three strains. Other additives include: ethylene diamine tetracetic acide,
monosodium glutamate, porcine gelatin, arginine, dibasic potassium phosphate, monosodium
phosophate. Unlike the intramuscular vaccine, no thimerosal is required in the preservative
manufuring of this vaccine.121
We should be forewarned that Baxter International is also in the swine flu game, although there
is no word yet on whether vaccine maker intends to replace chicken embryos with its new cell
culture systems research. According to Dr. Mae-Wan Ho, “Baxter International applied for a
patent on a process using cell culture to produce quantities of infecting virus, which are
harvested, inactivated with formaldehyde and ultraviolet light, and then detergent. Baxter has
produced H5N1, whole virus vaccines in a Vero cell line derived from the kidney of an African
green monkey… The main finding was that the toxic adjuvant did not increase neutralizing
antibodies against the vaccine strain.”122
Noting the fact that vaccines include a host of undisputed toxins, such as thimerosal, aluminum
phosphate, and formaldehyde, Alan Phillps reminds us that many of the ill effects caused by
vaccines existed at nowhere near today’s levels 30 years ago. He cites autism, ADD,
hyperactivity, dyslexia, and a host of allergies as examples.123 In his book What Every Parent
Should Know About Childhood Immunization, Jamie Murphy seconds the views of Phillips, and
pulls even fewer punches.
"What sane person would consider using a hazardous waste, carcinogenic in rats, used in the
manufacture of inks, dyes, explosives, wrinkle-proof fabrics, home insulation, and as a major
constituent of embalming fluid, and inject it into the delicate body of an infant? What could
formaldehyde, aluminum, phenol, mercury, or any number of other deadly chemical substances
used in vaccines possibly have to do with preventing disease in children? The fact that they are
needed at all in the vaccine formula argues that the product is toxic, unstable and unreliable with
or without their presence."124
The vast majority of scientists, physicians, nurses and public health educators’ trust that the
ingredients in a vaccine have been individually and synergistically proven safe and effective. The
public believes these vaccines, aside from their specified virus(es), are sterile solutions, free from
undesirable contaminants not listed on the manufacturer’s package inserts. When the
pediatrician injects a vaccine into the muscle of a child, the parents unquestioning faith that this
is the case. In other words, we want to believe that vaccines have been generated under perfect
conditions for the safety of children and ourselves.
Our investigation shows that most people do not know what is actually in a vaccine: the active
ingredients listed on product labels, inert ingredients, and, most important, the hidden
ingredients. Even more remote is taking the time to actually study the subject matter, review the
scientific literature and discover the truth for oneself. To our amazement, that truth was easy to
find. But it is a truth that will scare the hell out of you.
Similar to eating veal parmesan, what would happen if a video were placed on your table and
used as a living reality recipe instead of the actual meal. This video unfolds before your eyes
every step in that little creature’s life, from the veal’s birth to the parmesan on your plate. You
witness how this veal was starved of its natural nutrients, kept in a tiny stall, grossly
malnourished and deformed, filled with drugs—antibiotics—diseased and suffering complete
privations until finally slaughtered, sliced, cooked and served on your plate. Would your
appetite be the same? Would you still desire the parmesan? Conveniently we rarely ask the
questions, where does our food come from? How and where was it grown? What was sprayed on
it prior to our consumption? Therefore, we are going to re-record something that even most top
health educators and opinion leaders on vaccines are unaware of. That is, what goes into the
making of vaccines and what is hidden from you that should give you a moment’s of pause?
Then ask yourself, do you want vaccines in your body?
To give us the most in depth, honest, scholarly and objective examination about the methods by
which vaccines and their hidden ingredients are prepared we turn to the award-winning British
investigative medical journalist, Janine Roberts, who paints an entirely different picture about the
darker inferno in vaccines that do not appear on product labels. This is the same Janine Roberts
who brought to the world’s attention blood diamonds, genocide in the Congo and the destruction
of aboriginal cultures by the Australian government.
Roberts’ account of conversations between high level members from the World Health
Organization (WHO), federal health agencies, and expert vaccine scientists, who determine
whether or not a certain vaccine will be approved or not, is horrid. Her investigations are based
on official meeting documents and her attendance at emergency vaccine meetings, and confirm
that our world’s vaccine and health experts agree there is no solution in sight to resolve the
potential and uncertain threats posed by these hidden ingredients.125
The story begins with the vaccine industrial complex’s attempt to reduce vaccine manufacturing
costs by seeking government approval to use cancerous cell lines in the development of vaccines.
Vaccine industry’s rationale is that cancerous cells are “immortal.” Current vaccine methodology
relies on animal cells, such as fertilized hen embryos and monkey kidneys, that die quickly in
culture. Using cancerous cell lines are also much cheaper than relying on the purchase of
animals, especially monkeys, that need to be sacrificed for vaccine substrates.
Roberts records two separate meetings—a meeting of the Vaccine and Related Biological
Products Advisory Committee on November 9, 1998, and a subsequent gathering of the Evolving
Scientific and Regulatory Perspective Workshop less than a year later. The conversations were
conducted at a scientific level between top officials and expert scientists from the FDA, Centers
for Biologics Evaluation and Research (CBER), the National Institute of Allergies and Infectious
Diseases (NIAID), the WHO and others, each providing evidence and/or confirmation that all
vaccines are dangerously contaminated.
Conversations focused primarily on the influenza, MMR and yellow fever vaccines, which rely
on fertilized chicken eggs for their culturing viruses. Fertilized chicken eggs, while ideally suited
for culturing certain viruses for vaccines, such as the influenza and MMR vaccines, are also
living incubators for large numbers of known and unknown viruses in the animal kingdom.
While these do not transmit from their animal host to humans naturally, they nevertheless are
sequential genetic codes, which when injected into the human body, have the potential for any
number of unpredictable adverse effects by interfering or merging with the codes of human
cells. Vaccine research is at best a primitive science because it is injecting into the blood stream
foreign substances, chemical and genetic, that would otherwise not enter the body naturally.
When we include into the equation the enormous amount of known and unknown genetic
material and foreign proteins that vaccines introduce into the body, and then consider the rapid
increase in epidemics raging across the American population—adult diabetes in children, large
numbers of various inflammatory and immune deficiency diseases, asthma and new allergies,
severe gastro-intestinal disorders (eg., leaky gut syndrome and Crohn’s Disease), chronic fatigue
syndrome, and many different neurological disorders (eg., autism, ADD and ADHD,
Parkinson’s, Alzheimer’s, etc.)—we must step back and reconsider their causes. We should
avoid the kind of faith the vaccine industrial complex has in its determinist, reductionist
perspective of genetic materialism to find these answers without taking into account the
bombardment of toxic chemicals such as vaccine adjuvants and preservatives, extraneous genetic
material, and pathogenic organisms and foreign genetic fragments that we assault our bodies
from shortly after birth into old age.
For some time, it was known that the enzyme reverse transcriptase (RT) was present in final
vaccine solutions. RT has been used to this day as an indicator that there is a presence of a
retrovirus. During the meeting’s proceedings, the WHO decided to withhold public
announcement of such genetic contamination, in this case concerning the MMR vaccine, and
made the decision to not remove it from the market and, in the meantime, continue safety studies
at various laboratories.
Roberts reports that Dr. Arifa Khan from the FDA confirmed:
The RT activity in the vaccine was associated with retrovirus particles from two separate
viral strains: Avian Leuokosis Virus (ALV) and Equine Arteritis Virus (EAV). The
former was especially disturbing because ALV is a leukemia cancer, and Dr. Khan stated:
“There was a theoretical possibility that the virus [ALV] could… infect the [human]
cell.” In summary, this means the ALV genetic code could integrate with human DNA,
hence causing some kind of cancer.
The FDA’s reassurance that the ALV RT activity was safe is based on laboratory observations
that there was no viral-human DNA merger activity for “a full 48 hours’. This kind of assurance
is almost nonsensical and flies in the face of scientific reasoning since cancers can take years to
As a side note, reverse transcriptase activity is one of the stalwarts of the HIV/AIDS hypothesis.
An article, “Serious Questions Regarding the Safety and Efficacy of the Influenza Vaccine”
published by Canada’s Vaccine Risk Awareness Network reports that some studies, and even
some vaccine package inserts, “indicate that vaccinations increase HIV viral replication.”126
This means all vaccines stimulate a strong suppressive effect on the immune system. Under
stress conditions, viruses turn hyperactive and increase their ability to replicate.
The other risk stated by the FDA official was the possibility of the ALV sequence merging with
the measles virus, hence creating a completely new, mutant and dangerous virus. (This could
also apply equally to the H1N1 swine flu and any other flu vaccines). As an aside, the world
renown British geneticist Dr. Mae-Wan Ho from the Institute of Science in Society wrote that,
“Vaccines themselves can be dangerous, especially live, attenuated viral vaccines or the new
recombinant nucleic acid vaccines, they have the potential to generate virulent viruses by
recombination and the recombinant nucleic acids could cause autoimmune disease.”127
During the meeting, Dr. Andrew Lewis, then head of the DNA Virus Laboratory in the Division
of Viral Products confirmed that “All the egg-based vaccines are contaminated…. These
fertilized chicken eggs are susceptible to a wide variety of viruses.” The participants also
realized that only a very small fraction of these small contaminants have been identified and
there are likely hundreds more to be discovered.
Roberts found a 2001 CDC report showing that RT investigative studies for both the ALV and
EAV retroviruses were conducted in 100 patients receiving the MMR vaccine. They found
undesirable “RT activity in all measles vaccine lots from different manufacturers tested.” Their
conclusion is that “this occurrence is not sporadic and that vaccine recipients may be universally
exposed to these [chicken] retroviral particles.” In a separate National Institutes of Health
transcript of a meeting, Dr. Conroy of the World Health Organization stated that EAV viruses
are found in all fertilized chicken eggs. There appears to be little change in the scientific protocol
for making the influenza, MMR and yellow fever vaccines. The current release of intramuscular
H1N1 vaccines for the global market relies on the use of fertilized chicken embryos. These
include each of the approved vaccines by CSL, Medimmune, Novartis and Sanofi-Pasteur, as
well as GlaxoSmithKlines if and when it is approved in the US.
A later meeting of the FDA’s Scientific and Regulatory Perspective Workshop, without the
press, was convened on September 7, 1999 in Washington DC, and attended by “representatives
from all the largest public health institutions in the West.” The following are summaries of key
points and statements raised during this meeting as recorded in Janine Roberts invaluable book
Fear of the Invisible.
It was reconfirmed that vaccines are “widely contaminated by viral and DNA genetic code
fragments, many viruses and proteins. There was expressed concern that these may also
contain prions (tiny proteins responsible for incurable diseases and neurological disorders in
both humans and animals) and oncogenes (a gene that turns normal cells into cancerous
ones). One attendee, Dr. Goldberg, stated, “There are countless thousands of undiscovered
viruses, proteins and similar particles. We have only identified a very small part of the
microbial world—and we can only test for those we have identified. Thus the vaccine
cultures could contain many unknown particles.”
Dr. Andrew Lewis of the FDA said that a brand-new monkey-human mutant virus was
created during the course of creating an adenovirus vaccine with adenvovirus-SV40 hybrid
viruses. Dr. Lewis also worried that “foreign cellular DNA” common in childhood vaccines
could include “viral oncogenes” capable of causing cancer.
The scientists presented a question to themselves as to whether or not an attenuated vaccine
strain could revert into a variant virus capable of replicating so fast that it would cause AIDS.
They agreed that they were unable to answer this question.
On the question whether or not mutation events could occur in children after vaccination, the
answer was that “Recombination among a variety of viruses [contaminant viruses] and cells
co-infected in tissue culture is not uncommon.” What this basically means is that because it
is “not uncommon” for genetic codes of both contaminant viruses and living cells to
recombine and create mutations in laboratory cultures, it can certainly occur in a child’s body
after vaccination.
Dr. Hana Golding, Chief of CBER’s Laboratory of Retrovirus Research, raised the fear that
although DNA fragment contaminants in vaccines may be thought to be dead, they could
remain active and dangerous. This meant that the codes of these contaminants could combine
in vaccines and create new mutant strains of pathogens.
Dr. Leonard Hayflick, a virologist at both Stanford and the University of California at San
Francisco raised a concern that the common primary culture used for making vaccines with
animals and bird embryos has created a situation where it is “apparent that these cells
contained many unwanted viruses, some of which were lethal to humans.” This was
especially worrisome of those vaccines, such as polio, which still rely on monkey kidney
cells that have contributed to widespread death and illness.
One of the UK’s leading vaccine expert, Dr. Phil Minor from the National Institute of
Biological Standards and Control, noted that some cases of polio vaccine are polluted with
more monkey virus, SV40, than actual poliovirus. Although the uninitiated who are not
informed about-closed door vaccine science have been led to assume that SV40 was no
longer in polio vaccines at the time of this meeting, the conversations confirmed that it was
still in use. This is another example of deception at high levels within the vaccine industrial
complex and high government health officials to withhold information that directly impacts
the health and well being of citizens.
Dr. Rebecca Sheets from the CBER’s laboratory responsible for monitoring vaccine safety
stated the national health organizations had no control over how vaccines were made. In
short, they could make recommendations but the vaccine industrial complex was free to act
as it chooses.
It is impossible to remove DNA contaminants from vaccines. Although weight limits for
contaminating DNA were set by the FDA as far back as 1986, vaccine makers have never
been able to reach that goal. The CDC decided to limit their weight recommendation to
cancerous cell lines and then increase the other DNA contamination allowance one hundredfold. However, these limits are only “recommendations” and, therefore, the FDA is unable to
enforce them. Vaccine manufacturers continue to have the freedom to take scientific
measures to reduce contaminants only if they wish.
Remember, this level of contamination (10 nanograms) only applies to a single vaccine.
Children today are inoculated with many vaccines before entering school, each with unique
DNA and viral contaminants due to the specific cell substrates used for a given vaccine. This
toxic genetic soup is what then flows through a vaccinated person’s body.
One government health official stated, “I chaired the committee that licensed the chickenpox
vaccine, and it [residual DNA] was actually an issue that we considered at that time. We
looked among recipients of the vaccine for evidence of an autoimmune response associated
with the DNA included in that vaccine…… Actually, we didn’t look, we asked the company
to look and they did not find one.” Well, of course, only such assurances can be convincing
if in fact the company conducted the study, for which there was no compulsory reason to.
Clearly, what the official is saying is that health authorities may not possess any study
documents that such a study actually exists.
Can vaccine DNA contamination cause cancer or autoimmune disease? A meeting
participant responded, “when you consider that almost every one of these vaccines is injected
right into the tissue… I think you couldn’t do much more to get the DNA expressed [to get
contaminating DNA taken up by human cells] than to inject it into a muscle in the way it’s
being done.”
Again CBER’s Dr. Rebecca Sheets: “I think that the vast majority of licensed vaccines, US
licensed vaccines, have not been tested for residual DNA.”
A more frightening question was raised as to whether it was known if there has been any
presence of foamy virus. Foamy virus (HFV in human form and its more widespread parent
SFV from monkeys), although not infectious, is a deadly carcinogen. To the participants’
knowledge, they did not know whether any laboratory has ever searched for it in vaccine
The meeting confirmed that a particular cell, “which under many conditions is neoplastic
[tumor causing]” has been licensed for the production of both injectible and oral polio
vaccines in the US, Thailand, Belgium and France. Therefore, these vaccines carry the high
risk of containing cancer-causing oncogenes.
In order to appreciate the magnitude of the contamination problem in vaccine products, it is
important to understand that vaccine filtration needs to allow the targeted virus’s passage to
remain for vaccine use. Other particles and pathogens—DNA and RNA fragments from other
organisms (and pathogens) in the manufacturing process, cellular substrates, and viral proteins-smaller than the vaccine’s virus will remain in the vaccine.
What the content of these meetings tells us is best expressed by one of the leading attendants at
the meeting, Dr. Minor stated, “So even today then you have to bear in mind that a large amount
of vaccine that’s made is made on really quite crude materials, from an adventitious agent point
of view. It’s not a trivial usage. In fact, when considering what vaccines are actually made on
these days, they are quite primitive in some respects.” Janine Roberts summarizes her
investigations succinctly,
“In other words, the vaccines we give our children are liquids filled with a host of
unknown particles, most of which came from the cells of non-humans: from chickens,
monkeys and even from cancer cells. Truly we do not know what we are doing or what
are the long-term consequences. All that is known for sure is that vaccines are a very
cheap form of public medicine often provided by governments to assure the public that
they really do care for the safety of our children.”
The conclusion that can be drawn from these meetings convened by our national and
international health officials in vaccine science and safety is that vaccines are virtually genetic
experiments, capable of causing mass cellular destruction, being injected into the world’s
population, especially children. There remain so many unanswered questions about vaccine
science. This includes the forthcoming swine flu vaccines that will include the contaminants
mentioned above, if we take any of these meeting attendees’ words to heart.
If we are to express any awe and wonder it should be towards our body’s natural immune system
and its ability to defend itself from the onslaught of vaccine brews. It is not vaccination that is a
miracle of science, as the vaccine industrial complex, government health authorities and their
congregations of believers are too eager to proclaim. In fact, the real miracle is the body’s ability
to protect itself, in most cases, from the invasion of vaccines. Yet, even this statement is now
turning suspect given the dramatic rise in multiple illnesses and inflammatory conditions across
the age spectrum.
As with all living systems, whether it be a natural habitat in the wild, the planet’s climate system
to support life, or the body’s immune system, a tipping point is eventually reached. Today, with
the majority of the public still buying into the false promises of vaccination’s efficacy and safety,
the vaccine industrial complex remains an extraordinarily lucrative business. More and more
vaccines are now being developed for a wide variety of diseases and infections— Chlamydia,
herpes simplex type 2, West Nile virus, Epstein-Barr virus, and others—that will only add to the
overload of vaccines already recommended, especially to children who are officially
recommended to receive 36 separate vaccinations by the time they reach 18 months of age. As
these new genetic poisons are added to the national health agencies’ recommended vaccination
schedule, a tipping point may be reached that will result in a more serious pandemic, a pandemic
of Vaccine Disease, manifesting in myriad illnesses dependent upon each vaccinated person’s
genetic predisposition and the robustness of the immune system, than any epidemic threat posed
by wild infectious pathogens, including the H1N1 swine flu, that could unfold in our so-called
developed, hygienic society.
Thimerosal (Ethylmercury)
Thimerosal, the ethylmercury preservative commonly found in vaccines, is perhaps the most
controversial ingredient. Although thimerosal has been removed or greatly reduced from most
vaccines, it remains a major ingredient in flu vaccines. The pharmaceutical company Eli Lily
tested thimerosal back in 1930, giving it a clean record of safety even though its own trials had
shown this highly toxic form of mercury had caused serious neurological damage and even death
in both animals and humans. During that decade, a competitor vaccine maker, Pittman-Moore,
had also conducted toxicological studies, but with dogs, on thimerosal and concluded the
preservative was “unsatisfactory as a serum intended for use on dogs.” “Eli Lily Knew of
Thimerosal Dangers for Decades” June 18, 2009. During the Second World War, vaccines with
thimerosal were required to be labeled as “poison,” and later in 1972, Eli Lily itself discovered
that thimerosal in doses a hundred times weaker than in a typical vaccine at that time, was “toxic
to tissue cells.” Nevertheless, the drug maker continued to promote the illusion that thimerosal
was safe and highly suitable as a vaccine preservative. Government health officials and vaccine
manufacturers to this day have known of the long history of research confirming thimerosal as a
toxic poison unsuitable for human delivery. A former leading vaccine developer for Merck had
once warned his firm of the dangers of administering mercury-laced vaccines to newborns and
infants and declared that the industry knows very well there are “nontoxic alternatives” that were
equally effective and could be used to replace thimerosal.
Dr. Hugh Fudenburg, a leading immunologist and founding director of Neuro Immuno
Therapeutic Research Foundation, is one of the most quoted immnogeneticists of our times, with
over 850 papers in peer-reviewed publications. After years of immunological study, he
discovered that individuals who had had five consecutive flu shots between 1970 and 1980, the
changes of acquiring Alzheimer’s Disease were ten times or 1000% higher than those who had
only one or two vaccinations during that same time period. “Flu Shots and Alzheimer’s
There is plenty of independent scientific evidence that shows trace amounts of mercury cause a
particular nerve damage reminiscent of that frequently found in Alzheimer’s patients. The
University of Calgary Medical School identified an abnormal nerve formation, known as
neurofibrillar tangles, which is one of the two primary diagnostic markers for verifying
Alzheimer’s, in samples exposed to mercury. Other research shows that mercury is also one
causative agent for the formation of the other Alzheimer marker “amyloid plaque.” Dr.
Lorscheider of the International Academy of Oral Medicine and Technology has produced a film
showing how the introduction of mercury into a living organism will induce these two critical
markers for Alzheimer’s. http://commons.ucalgary.ca/mercury. The nationally renown
toxicologist Dr. Boyd Haley at the University of Kentucky has stated, “Seven of the
characteristic markers that we look for to distinguish Alzheimer’s disease can be produced in
normal brain tissues, or cultures of neurons, by the addition of extremely low levels of mercury.”
NeuroReport. 2001. 12(4)L 733-737
Certainly, parents want to protect their children from debilitating and life threatening viral
infections, and many parents therefore hold faith in the protection vaccination claims offer.
However, one aspect of vaccination that has fueled considerable controversy is the use of
thimerosal (which is approximately 50% percent ethylmercury by weight) as a preservative. This
substance was contained in vaccines for many decades before the U. S. Public Health Service
and the American Academy of Pediatrics issued a statement in 1999 urging its removal.129
Although the PHS agencies and AAP said this step was being taken as a precautionary
measure—not because the mercury in vaccines had caused harm—the fact remains that as more
vaccines were being mandated for children, the cumulative level of mercury to which some
infants were exposed through vaccination exceeded that deemed safe by a federal guideline.130,
Thimerosal, or ethylmercury, is a manmade neurotoxin and up until 1999 it was simply assumed
to have the same toxicological profile as methyl mercury. Since then, the toxic differences
between these two mercury compounds have been found to be critical. Even a more conservative
group of researchers at The Macfarlane Burnet Institute for Medical Research and Public Health
in Australia, were compelled to conclude that “there is an increased sensitivity of the fetal brain
to mercury whether it is ethyl or methyl mercury. While there is no evidence to support the
contention, it is at least theoretically possible that very low birth weight premature infants may
be at increased risk from thiomersal-containing vaccines.”132
On July 9, 1999, the American Academy of Pediatrics (AAP) issued a statement urging removal
of the mercury-containing preservative thimerosal from vaccines.133 Thimerosal has since been
eliminated from or reduced to trace amounts in all of the vaccines routinely given to children age
6 and younger, reports the FDA. The only exception for this age group is the influenza vaccine,
for which a limited supply of a preservative-free version was available in 2006.134 (Trace
amounts of thimerosal may remain in some vaccines given to children because it is used in the
manufacturing process, not from its use as a preservative). With the new vaccines (excluding
influenza), the maximum cumulative amount of ethylmercury an infant would be exposed to in
the first six months of life through routine vaccinations is now <3 mcg. This exposure is down
from a maximum of 187.5 mcg previously.135
The reason behind this strong recommendation for the removal of thimerosal is a growing
concern about the risk of exposing the developing brains of infants to mercury. While the
precaution is certainly welcomed, we should ask why such a dangerous, known neurotoxin was
allowed into vaccines in the first place. As far back as the early 1930s, along with thimerosal’s
hazardous dangers to human health, its effectiveness as an antimicrobial preservative was being
questioned by the scientific community. During congressional hearings in June 2002,
Congressman Dan Burton pressed government health officials on the safety of mercury in
vaccines. He uncovered that thimerosal has been used in vaccines since 1929 and only one study
was known to have been performed on thimerosal’s safety in all that time. That one test was
done by thimerosal’s inventor, Eli Lilly, and much of the tests results were concealed because of
the pending approval of a vaccine by Lilly using thimerosal.136
Mercury exposure has been associated with nerve cell degeneration,137 adverse behavioral
effects138 and impaired brain development.139 It has also been linked to degenerative chronic
conditions such as Alzheimer’s disease. The developing fetal nervous system is the most
sensitive to its toxic effects, and prenatal exposure to high doses of mercury has been shown to
cause mental retardation and cerebral palsy.140
At the center of the debate over the use of mercury in vaccines is whether this substance has
contributed to an increased incidence of autism in the U.S. An analysis of VAERS found that
mercury exposure from thimerosal-containing vaccines (TCVs) was a significant risk factor for
neurodevelopmental disorders (NDs).141 Other research, as discussed by David Kirby in
Evidence of Harm, has suggested an association between mercury in the body and autism.142, 143,
144, 145
However, a number of population studies have found that there is no association between
TCVs and the incidence of autism spectrum disorders.146, 147, 148 The Institute of Medicine
determined in a 2004 report that “the body of epidemiological evidence favors rejection of a
causal relationship” between TCVs and autism and between the MMR vaccine, in particular, and
Concerns about the safety of mercury in vaccines continue. In 2006, Washington State passed a
law banning the use of thimerosal in vaccines given to young children and pregnant women. This
law made Washington the seventh state—after Iowa, California, Delaware, Illinois, Missouri,
and New York—to limit the use of mercury in vaccines. More than a dozen other states have
introduced similar legislation.150
A continuing concern is the use of thimerosal in vaccines that may be given to children age 7 and
older (such as some flu and tetanus-diphtheria vaccines) and to adults who are elderly or immune
compromised. The CDC recommended in 2004 that children 6-23 months of age receive the flu
vaccine each year, and in 2003 it approved the “first live attenuated influenza vaccine licensed
for 5-49 year old persons.”151 As late as the 2004-2005 flu season, however, two types of
influenza vaccines were still on the market: some contained thimerosal as a preservative and
some were preservative-free. The CDC said then that the amount of preservative-free flu vaccine
would continue to increase as the capabilities of manufacturers grew.152 However, one wonders
how many children are still suffering the effects of mercury-toxic injections from past flu
The FDA, for its part, says that with the maximum cumulative exposure to mercury for children
under 6 months reduced to less than 3 mcg, “an infant could receive a thimerosal-containing
influenza vaccine at 6 and 7 months of age.” The FDA reasons that the maximum exposure from
routine vaccinations would be 28 mcg, which is “well below the EPA calculated exposure
guideline for methylmercury of 65 micrograms for a child in the 5th percentile body weight
during the first 6 months of life.”153
The Vaccine-Autism Coverup
What you are about to read are some of the exact words by high level pro-vaccine officials in the
government health agencies, their academic medical advisors and leading representatives in the
vaccine industrial complex. These are the people who shape the propaganda about vaccine
safety. Essentially they to assure us there is no relationship between mercury in vaccines and the
epidemic rise in autism. The words are from a transcript of the now infamous secret meeting held
by high level officials and scientists from the CDC, FDA, World Health Organization and
representatives of every major vaccine manufacturer, including GlaxoSmithKline, Merck, Wyeth
and Aventis. This private meeting was held at a Christian retreat center in Simpsonwood,
Georgia, during June of 2000. Thanks to the diligent efforts of Robert Kennedy Jr. and his filing
a Freedom of Information Act, the 262 page official transcript of the gathering has been removed
from obscurity and can be read on the Internet at www.autismhelpforyou.com. Some of the
more important statements made during this meeting have been highlighted by Robert Kennedy,
Jr. with an excellent commentary in a 2005 Salon.com article, “Deadly Immunity,” which we
rely on here.
The closed Simpsonwood meeting was urgently called to address the results of an alarming CDC
control study. CDC epidemiologist, Dr. Tom Verstraeten, after analyzing medical records of
100,000 children, noted the preservative thimerosal commonly used in vaccines, and which are
listed as an ingredient in all the new intramuscular swine flu vaccines, was the very likely culprit
for the large increase Autistic Spectrum Disorders—which include ADD, ADHD, speech
problems, etc.—and neurological conditions being witnessed in vaccinated children. He stated,
“I was actually stunned at what I saw.” A top consultant for the American Academy of
Pediatrics, Dr. Bill Weil, told the assembly, “you can play with this all you want… [the results]
are statistically significant.” Dr. Richard Johnston, a pro-vaccine immunologist and pediatrician
from the University Colorado excused himself early from the gathering after stating, “Forgive
my personal comment—I do not want my grandson to get a thimerosal-containing vaccine until
we know better what is going on.”
But, much of the meeting’s discussion dealt with how the parties might cover up the CDC
study’s findings in order to avoid what Dr. Robert Brent, a leading pediatrician at Alfred DuPont
Hospital for Children in Delaware, called a “bad position from the standpoint of defending
lawsuits.” Dr. John Clements, vaccine advisor for the World Health Organization stated the
research “should not have been done at all….. [the study] will be taken by others and will be
used in ways beyond the control of this group.” Let us remember, these are the voices of the
same expert scientists and the leading pro-vaccine spokespersons who for years denied publicly
any relationship between immunization and childhood neurological disorders. These are also the
guiding voices behind the very same CDC and professional medical association websites where
we are directed to visit repeatedly to learn about vaccine safety and all the wonderful miracles it
has to offer us.
The rest of this story is well documented and deals with how the CDC made attempts to hide the
study by depositing the evidence of the meeting with a private firm and then whitewashing
thimerosal’s health dangers with subjectively re-designed studies published in subsequent years
and released for dissemination through national health agencies and professional medical
associations for pediatricians to follow obediently.
Something vaccine administering health practitioners and doctors are unaware of is that many
people are hypersensitive to ethylmercury in vaccines, and result in allergic outbreaks and
asthma. This was discovered during the course of research undertaken by the WHO’s Initiative
for Vaccine Research. Separate research reported by the same group found the same true for
aluminum adjuvant and resulted in persistent adverse symptoms repeatedly after vaccinations.
How many of people do you know who have been tested to determine whether or not they are
allergic to either ethylmercury or aluminum?154
In February 9, 2004, fifteen research scientists and medical doctors presented their findings on
whether or not there is a direct relationship between vaccines and autistic spectrum disorder to
the Immunizations Safety Review Committee of the Institute of Medicine of the National
Academies. A review of the transcript and summaries of the meeting showed that:
60% (9) individuals felt there was a link to autism. None of these persons had conflict of
interests with the private vaccine and/or health industries
26% (4) felt there was not a connection. All of these individuals had connections.
14% (2) were noncomitted and both an uncertain relationships to private industry.155
Evidence for the Thimerosal-Autism Connection: The Research of the Geier’s
During the past 5 years, Dr. David Geier and his son Mark Geier at the Institute of Chronic
Illnesses in Silver Springs, Maryland, have been conducting the most thorough epidemiological
and toxicological studies on the possible relationship between thimerosal or ethylmercury used in
vaccines and the high incidence of neurological impairment in vaccinated children. In fact the
Geiers were the first in the US to conduct and publish such epidemiological studies to map the
trends vaccinations with and without thimerosal and the rates of autism spectrum disorders
(ASD). The Geiers were originally skeptical that there was any relationship between thimerosal
and ASD; however, the on-going studies convinced them otherwise. For the Geiers, the continual
use of thimerosal is a “medical crisis” and, therefore, a separate section devoted to their research
is warranted.
Although the Geiers do not rule out genetic factors associated with pathogenetic developments in
ASD, their research convincingly shows that “mercury exposure can induce immune, sensory,
neurological, motor, and behavioral dysfunctions similar to traits defining or associated with
ASDs.”156 Not only do their studies focus on the effects of thimerosal during the vaccination
regimen of children but also mercury’s neurological effects during the neonatal period of an
infant’s development. While the vast majority of attention to thimerosal is placed on its use as a
preservative in vaccines, the compound is also used in other products such as nasal sprays, eye
solutions, and other injectable biological products, including Rho(D)-immune globulin which is
given to pregnant Rh negative women.
Beginning in 2003, the Geiers noted that the rapid increase in autism in the US, from 1 in
approximately 2,500 in the mid-1980s to 1 in approximately 300 children in the mid-1990s (as of
2007, the ratio is now estimated at 1 in approximately 150) could correspond to the rise in the
number of childhood vaccinations before the age of 2 years. The researchers stated that “the
evidence presented here shows that the occurrence of neurodevelopmental disorders following
thimersosal-containing childhood vaccines does not appear to be coincidental.” 157 A subsequent
study published the same year compared adverse neurodevelopment reports with the diphtheria,
tetanus, acellular pertussis (DTaP) vaccine—those containing thimerosal and those that were
thimerosal-free. Their research was based on the review of tens of millions vaccines
administered in the U.S.158
In 2004, they performed a similar study but looked at the measles, mumps and rubella (MMR)
vaccine and ASD trends. There results corroborated with their earlier DTaP investigation that
“there is biological plausibility and epidemiological evidence showing a direct relationship
between increasing doses of mercury from thimerosal-containing vaccines and
neurodevelopmental disorders.” More startling for the Geiers was an additional potential
relationship between the MMR vaccine itself and ASD. This convinced them in their study’s
conclusions that “thimersosal be removed from all vaccines and additional research be undertaken
to improve the MMR vaccine with an improved safety profile.”159
In 2006, the Geiers performed the first major epidemiological study, an “ecological study” to
access the trends in certain reported neurological disorders—autism, mental retardation and
speech disorders—in the Vaccine Event Reporting System (VAERS) between the years 1991 and
2004. This was a follow up of several earlier epidemiological studies.160 161 The latter years of
this timeline correspond to when thimerosal was removed from vaccines. It found “significant
reductions in the proportion of NDs reported to VAERS as thimerosal was begun to be removed
from childhood vaccines in the US from mid-1999 onwards.”162
One of the Geiers more recent studies, sponsored by the Office for Human Research Protections,
U.S. Department of Health and Human Services, screened a group of autistic children with only
known exposure to mercury via vaccine thimerosal. Eight of the nine patients screened—each
who was developing normally prior to the manifestation of encephalopathic traits—were
exposed to significantly higher mercury levels from Thimerosal-containing biologic/vaccine
preparations during their fetal/infant developmental periods, and subsequently, between 12 and
24 months of age. The follow adverse effects were common to each of the children under
had regressive ASDs ;
had elevated levels of androgens;
excreted significant amounts of mercury post chelation challenge;
had biochemical evidence of decreased function in their glutathione pathways;
had no known significant mercury exposure except from Thimerosal-containing
vaccines/Rho(D)-immune globulin preparations;
had alternate causes for their regressive ASDs ruled out.
Their conclusions are that thimerosal intoxication should be considered as a component in the
diagnosis of some regressive ASDs.163
Many pregnant women are administered an injection of Rho(D) immuno globulins, better known
as TCRs, containing thimerosal. Drs. David and Mark Geier conducted a race-matched
controlled study of Rh negative women who received TCRs, the toxicity levels and effects of
mercury on neonatal development, and the rate of autism in children.164 The results showed that
autistic children were significantly more likely to have Rh-negative mothers than those in the
control group, and that each ASD child’s mother was determined to have been administered a
TCR with thimerosal during her pregnancy. The implications of the study seem to indicate that
unborn children exposed to mercury by their mothers having received drugs and/or vaccines
containing thimerosal might contribute to later neurological impairment.
This paper stands by the opinion expressed by Dr. Joseph Mercola, a physician and health
activist, who explains, “There can be no argument that unnecessary mass injection of millions of
children with a vaccine containing an adjuvant known to cause a host of debilitating autoimmune
diseases is a reckless, dangerous plan.” Newman, Alex. “Risks of the Swine Flu Vaccine”
Dr. Mercola is referencing the documented adverse side effects of the adjuvant known as
The dangers of squalene have been known since its inventor Dr. Jules Freund warned back in
1956 that it was responsible for incurable conditions: experimental allergic encephalomyetlitis,
allergic neuritis, allergic aspermatogenesis, and other autoimmune diseases.165
Squalene is not listed in any of the package inserts for any of the swine flu vaccines approved for
use in the United States. Health officials are stating the vaccines are non-adjuvanted. An
unconfirmed report shared with us by a physician and international vaccine expert says there is
now information that squalene will not be listed as an ingredient in the recently approved H1N1
flu vaccines to be administered in the US. Of course, in Canada and Europe, squalene is
approved; therefore, it will be in their vaccines and listed accordingly on the package labels.
However, this unconfirmed report claims there are plans to distribute squalene separately, with
the actual vaccine vials, to those health professionals, hospitals and agencies that will be
administering the vaccine. Health officials have in fact ordered millions of dollars of shark oil,
which is the primary source for manufacturing squalene. The question arises as to what possible
purpose can such large amounts be ordered if our health officials are on record saying the
vaccine will not contain an adjuvant?
The prestigious Cochrane Collaboration, an independent medical research group without any
affiliations with private drug makers, reviews drug research and develops concise objective
reports on drug and vaccine efficacy and safety. Cochrane’s coordinator of vaccines, Dr. Thomas
Jefferson, stated that “New vaccines never behave in the way you expect them to do... But it
could end up being anything because one of the additives in one of the vaccines is a substance
called squalene, and none of the studies [from the drug makers] we’ve extracted have any
research on it at all.”166 In summary, the new swine flu vaccines will have a potentially diseasethreatening ingredient. What squalene research, independent of the pharmaceutical industry, has
been performed to determine its adverse effects?
There is a growing consensus among doctors, researchers, health agencies and independent
medical laboratories that flu vaccines are largely ineffective in protecting people from infection.
Squalene is a precursory biomolecule to cholesterol that directly stimulates the body’s immune
system. It is now known that the pandemic H1N1 vaccines now being manufactured by six
pharmaceutical companies will contain one of two squalene adjuvant formulas: AS04
(GlaxoSmithKline) or MS59 (Novartis). In May 2009, the government HHS contracted the
production of these two squalene formulas, at a cost of $283 million, in an effort for rapid
readiness for launching a national swine flu vaccination campaign.167
The Karolinska Institute has been conducting clinical studies on the safety of injectable squalene
adjuvant oil since 2000 and has documented repeatedly its association with adverse
immunological responses contributing to T-cell mediated induced arthritic conditions. It has
been proven to give rise to pathogenic cells developed within the lymphatic system.168
The introduction of squalene oil, first, provokes a burst of pro-inflammatory arthritogenic cells in
the lymphoid organs and, second, transmits arthritogenecity to other lymph nodes that in turn
precipitate disease in peripheral joints.169
Histopathological analyses have also shown that rats injected with the adjuvant oil quickly
showed signs of bone and cartilage erosion, indicative of polyarthritic diseases.170
Yet such a relationship between such oil-based adjuvants and polyarthritis and their adverse
interaction with the lymph system was known back during the mid-1960s in veterinary research
and with further confirmatory data produced in the 1980s.171
According to investigative journalist Gary Matsumoto, there is a “close match between the
squalene-induced diseases in animals and those observed in humans injected with this oil:
rheumatoid arthritis, multiple schlerosis, and systemic lupus erythematosus.172 Matsumoto
writes, “There are now data in more than two dozen peer-reviewed scientific papers, from ten
different laboratories in the US, Europe, Asia and Australia, documenting that squalene-based
adjuvants can induce autoimmune diseases in animals.” One example, was UCLA Medical
Center’s study back in the 1970s to find oils that induced autoimmune disease. “Rats injected
with… squalene all developed experimental allergic encephalomyelitis… The injected animals
were left hobbled, dragging their paralyzed hindquarters through the wood chips of their
Sweden’s Karolinska Institute has demonstrated that squalene alone can induce he animal
version of rheumatoid arthritis. The Polish Academy Sciences has shown that in animals,
squalene alone can produce catastrophic injury to the nervous system and the brain. The
University of Florida Medical School has shown that in animals, squalene alone can induce
production of antibodies specifically associated with systemic lupus erythematosus.”174
A Tulane University Medical School study published in Experimental Molecular Pathology
concluded its findings on the incidence of Gulf War Syndrome related to antibodies to squalene:
“The substantial majority (95%) of overly ill deployed GWS patients had antibodies to squalene.
All (100%) GWS patients immunized for service in Desert Shield/Desert Storm who did not
deploy, but had the same signs and symptoms as those who did deploy, had antibodies to
squalene…. In contrast, none (0%) of the deployed Persian Gulf veterans not showing signs and
symptoms of GWS have antibodies to squalene.”175
It can take many months and years for the adverse immunological effects of squalene to appear.
Irresponsible clinical trials for vaccine safety lasting several weeks are unable to evaluate the
long-term effects of squalene poisoning. An article appearing in the German magazine Der
Spiegel suggests that the mass vaccination on Europeans with squalene adjuvant vaccines is
nothing more than a free experiment being provided to the FDA before the US approves
squalene for the vaccine industrial complex.176
International vaccine expert and historian Dr. Vera Scheibner lists the following diseases and
conditions having been associated with squalene: arthritis, fibromyalgia, lymphadenopathy,
chronic fatique, abnormal body hair loss, non-healing skin lesions, aphthous ulcers, memory
loss, seizures, neuropsychiatric problems, anti-thyroid effects, anaemia, elevated erythrocyte
sedimentation rate, systemic lupus erythematosus, multiple sclerosis, ALS, Raynaud’s
phenomenon and Sjorgren’syndrome.
The biotechnology firm Chiron Corporation first developed squalene adjuvant, known as MS59.
Before being purchased by the multinational pharmaceutical company Novartis, Chiron was a
leading vaccine research and development firm. Novartis is currently in the forefront among the
drug manufacturers preparing the release of a swine flu vaccine, which will include squalene as
an adjuvant. The company announced as early as June 12 their preparedness to release its first
batch of H1N1 vaccine in early fall. A review of the studies contradicting squalene’s health risks,
in addition to negating the body’s immunological response against squalene, reveal that Novartis
Vaccines has been a major source behind this research with the specific goal of trying to extend
its safety profile for use in its vaccine development.177
Aluminum salts are the most common adjuvants used in vaccines. These salts increased in use
after federal legislation required the removal or reduction of thimerosal from vaccines. However,
after 2007, aluminum has no longer been used in flu vaccines in developed countries for the
simple reason it has very little effect in boosting immunity. Instead, vaccine manufacturers,
notably Novartis and GlaxoSmithKline, have been relying on their proprietary squalene
preparations, MS59 and AS03 respectively. Both companies reamain adamant that their squalene
adjuvants are safe.
Although aluminum will not found in the forthcoming flu vaccines, in addressing the issue of
negligent science in conducting clinical safety trials and corruption within the vaccine industrial
complex, we should look at the recent controversy over Merck’s Gardisil vaccine for the HPV
virus. Gardisil includes a reactive form of aluminum as an adjuvant.
The CDC’s National Vaccine Information Center in June 2006 came out with a statement against
the “universal use” of Merck’s Garasil for all pre-adolescent girls. According to NVIC’s
president, Barbara Loe Fisher, “Merck’s pre and post-licensure marketing strategy has positioned
mass use of this vaccine by pre-teens as a morality play in order to avoid talking about the
flawed science they used to get it licensed.”178 Review of the trail studies notes that the FDA
“allowed Merck to use a potentially reactive aluminum containing placebo as a control for most
trial participants, rather than a non-reactive saline solution placebo. A reactive placebo can
artificially increase the appearance of safety of an experimental drug or vaccine in a clinical
trial.179 Nearly 90 percent of Gardasil recipients and 85 percent of aluminum placebo recipients
followed up for safety reported one or more adverse events within 15 days of vaccination.180
The NVIC believes the clinical trial investigators dismissed even the 17 deaths that may have
been caused by the vaccine.181 Through a Freedom of Information request by Judicial Watch, a
public interest group investigating government corruption, information was gained showing that
there were 3 deaths early on, including one report of a woman who “died of a blood clot three
hours after getting the Gardasil vaccine.” Two others died of heart problems and/or blood
Aluminum compounds, most commonly aluminum hydroxide, have been used as adjuvants in
vaccines for eighty years.
Very recent studies conducted by neuroscientist Dr. Chris Shaw at the University of British
Columbia are showing a link between the vaccine adjuvant aluminum hydroxide and symptoms
“associated with Parkinson’s, amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease) and
Alzheimer’s. Shaw’s study, conducted in mice, used the same anthrax vaccine used during the
first Gulf War and which has been proven to cause Gulf War Syndrome in approximately 25
percent of 697,000 military personnel who were vaccinated. Why Shaw believes his study was
different than others is that the symptoms appeared around five months after immunization. As
we have seen above, the typical vaccine trial conducted by vaccine makers lasts only 2-3 weeks.
His team also observed notable memory loss 41 times higher than in the control group.
According to Shaw, there are thousands of studies showing aluminum hydroxide is a safe
vaccine adjuvant, but none of those studies look beyond the first several weeks after injection for
serious side effects.
In addition to squalene, aluminum was also used as a adjuvant in the anthrax vaccine during the
first Gulf War. Mouse studies the same vaccine as given to military personnel noted increased
incidences of amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease) and other neurological
conditions. There was noticeable cognitive deficits and motor neuron loss due to apoptosis. The
research however was unable to conclude that these detrimental effects were due to aluminum
alone or in combination with squalene, which was also among the vaccine’s ingredients. Petrik
M, Wong M, Tabata R, Garry R, Shaw C. “Aluminum adjuvant linked to gulf war illness induces
motor neuron death in mice.” J Neuro Molecular Med. 2007, February. 9(1)
Some of the research to discover aluminum-adjuvanted vaccines toxic levels and their adverse
effects have found the following:
Aluminum inflicts strong neurotoxicity on primary neurons.183
Aluminum-laced vaccines increase the aluminum levels in murine brain tissue leading to
Aluminum hydroxide, the most common form of adjuvant used in vaccines deposits
mostly in the kidney, liver and brain.185
Long term exposure to vaccine-derived aluminum hydroxide (which is today an
ingredient in almost all vaccines) results in macrophagic myofastitis lesions.186
Although alum and aluminum hydroxide remain highly toxic adjuvants, geneticist Dr. Mae-Wan
Ho that “numerous new adjuvants are no better, and could be worse.”187 In a recent article
published in a pharmaceutical magazine, BioPharm International, newer adjuvants, including all
the squalene formulas, have “substantially higher local reactogenicity and systemic toxicity than
Formaldehyde is used in some vaccines, including the flu, polio and DTaP shots, because it is
believed to eliminate harmful effects of toxins used in the vaccine and to prevent the viral
component from replicating and causing infection.189
Formaldehyde is also a classified human carcinogen and is frequently listed as an ingredient in
manufacturer’s vaccine packaging, including several flu vaccines. During the preparation process
to inactivate a virus, formaldehyde is commonly used. Formaldehyde has been suspected of
being a human carcinogen since the early 1980s, but it was not until 2004 that the International
Agency for Research on Cancer officially classified the chemical as a carcinogen, responsible for
nasopharyngeal, hematopoietic and lymphatic (leukemia) cancers. Although the studies to
establish formaldehyde’s relationship to cancer were conducted among those who were
frequently exposed to the chemical via inhalation, the molecule is known to be moderately
unstable once in the physical body and can therefore contribute to more serious systemic cancers,
such as myeloid leukemia. Therefore, the thought of injecting formaldehyde into the body’s
bloodstream, especially in small children, should be unthinkable to any rational person.
Among some of the more serious ingredients in common flu vaccines are:
Afluria (CSL Biotherapies)
Fluraix and FluLaval (GlaxoSmithKline)
Fluviral (Shire)
Fluvirin (Novartis/Chiron)
Fluzone (Aventis Pasteur)
Vaxigrip (Sanofi Pasteur)
Begrivac (Wyeth)
Fluarix and FluLaval (GlaxoSmithKline)
Fluviral (Shire), Fluzone (Aventis Pasteur)
Influvac (Solvay), Vaxigrip (Sanofi Pasteur)
Chick protein:
Afluria (CSL Biotherapies)
Begrivac (Wyeth), Enzira (CSL)
Flurarix and FluLaval (GlaxoSmithKline)
Fluviral (Shire), Fluvirin (Novartis/Chiron)
Fluzone (Aventis Pasteur)
Inflexal (Sanofi Pasteur)
Influvac and Mastaflu (Solvay)
Fluad (Novartis/Chiron)
Focetria (Novartis)
Fluraix (GlaxoSmithKline)
Fluzone and Mutagrip (Aventis Pasteur)
Fluzone (Aventis Pasteur)
Fluraix (GlaxoSmithKline)
FluMist-nasal (Medimmune)
Dog Kidney Cells:
Optaflu (Novartis)
So what have we learned? To our surprise we are outraged that we have been lied to repeatedly.
We believe the sacred halls of science have been co-opted and corrupted by the pharmaceutical
and vaccine industry and their search for ever-increasing proprietary money-making drugs. Let
us be clear, vaccines are medicines. They are drugs. That is, many of the scientists promoting
them have financial interests, and therefore, a bias. At worst, they are dishonest. We are also now
aware that dozens of, hitherto, respected pharmaceutical companies do not deserve our respect,
because they have been found guilty of falsifying drug trial results, price fixing, providing
financial inducement to researchers and physicians, and lining the politicians pockets with
consultants, lobbyists and foundations, all of who ultimately influence the CDC’s scheduling of
vaccines for children and adults.
We have also learned that what we call vaccine science does not exist. The biggest
disappointment is that this truth was in front of us all along. All it would have required was an
awareness that if a company had lied to repeated in the past about the safety and efficacy of its
drugs, why should be suspend all critical judgment and assume they would be honest all of a
sudden about vaccines. Pharmaceutical companies have spent hundreds of billions of dollars
settling lawsuits. Their drugs have killed hundreds of thousands of innocent Americans over the
decades. Can you imagine that one drug, Vioxx, killed 53,000 people and caused over 100,000
strokes and heart attacks, and still the company gets a bonus? We have learned that real medical
and scientific researchers and investigators, who did their homework and who were not
influenced by special interests groups or any political and economic pressure, can find no long
term double-blind placebo having been conducted to legitimize claims that vaccines are effective
and safe. On the contrary, they found numerous studies that for fully vaccinated individuals
coming down with the very disease for which they were vaccinated. They also showed that
thousands of individuals have received compensation from the federal government due to
vaccines. In addition, they have showed that the FDA, CDC and the HHS were fully aware that
there were connections between vaccines and illnesses; but, they chose to either downplay it or
cover it up, which supports the notion that there is a conspiracy between governmental health
agencies and the vaccine industrial complex.
We believe we have also discovered that brave, courageous scientists, physicians, journalists and
citizens, who have found the truth about vaccines, have been slandered, libeled and attacked for
their truths. Recently an American Senator said the banks on Wall Street own Congress.
Truthfully, he could have added the pharmaceutical industry as well. We must now begin an
honest, open and scientific effort to prove what really protects the body from pathogens and what
actually weakens it and makes it more susceptible to disease and illness. We should surrender the
paradigm that vaccination represents immunization and protection when no sound objective
science proves that to be the case. To the contrary we now have hundreds of thousands of
children in Autistic Spectrum Disorders and a sound science to show that single and multiple
vaccines, with their adjuvants and preservatives are clearly suspect. Yet, the vaccine industrial
complex continues to deny it.
Across the country, lobbyists representing private vaccine manufacturers have been selling the
story that the government must make certain vaccines mandatory with no exceptions. And it
should be noted, if there should be a big mistake and thousands or millions of people should
become seriously injured or die everyone in the vaccine industrial complex, especially the
vaccine makers, should be indemnified.
Several years ago, during production of my first three award-winning documentaries on Gulf
War Syndrome, it was surprising to interview so many soldiers who said they suffered from Gulf
War Syndrome—with real serious physical and neurological illnesses—who never fought
overseas during the war. They did not have Post Traumatic Stress Disorder, which is a frequent
a result of combat; but, they all had something else in common. They had all been given multiple
vaccines, including the anthrax and botulism, which contained the adjuvant squalene. Many
were too sick after receiving the vaccine to deploy overseas. Yet for eighteen years, all of the
400,000 veterans who are sick with Gulf War Syndrome have been denied the truth of what
actually caused their debilitating illnesses.
Further, we have also learned that very few cases of adverse effects have been recorded by the
federal authorities that are at least available to independent scientists, researchers and journalists.
Consequently, there is no actual number as to the true number of people who have been injured
or died from vaccines.
In conclusion, we should ask for national public debates between those who advocate for
vaccines and those who challenge them. We believe it is imperative to have this dialogue so we
can enable the public to decide for themselves as to whether or not they approve of the new
experimental H1N1 vaccine, and all vaccines collectively. Then let the public decide. In a real
democracy, an informed patient should have freedom of choice in health decisions. Today, there
is no honest debate, no informed consent, no real science, no transparency of vaccine research,
and no accurate statistics. Instead, we have federal health agencies, such as the CDC, on its own
website, making false claims by misinterpreting pneumonia as influenza. Obviously, this is
surely not the case. Finally, it is worse that the power of federal and state governments are being
used to mandate the enforcement of a scientifically unproven vaccine, namely the H1N1 swine
flu vaccine, in a totalitarian manner upon its citizens. This is not democracy, this is medical
Richard J. Gale
Gary Null, Ph.D.
Nutrition Institute of America
2307 Broadway
New York, NY 10024
NANOMEDICINE: Vaccines for the Twenty-first Century
Adjuvants such as aluminum hydroxide and squalene are antigen specific; that is, their strength
is not uniform and are either weaker or stronger depending on the specific viral antigen being
used. The new science of nanomedicine claims to show promise in developing a new kind of
adjuvant that is far more effective, and believed to be more safe, than conventional adjuvants.
According to independent scholar and investigator F. William Engdahl in Germany, “Vaccines
which have been approved by the responsible government authorities for vaccination against the
H1N1 Influenza A Swine Flu have been found to contain nano particles.” The governments in
question are “Germany and other European countries.” 190
Nanomedical researchers are touting these new micromolecules as “smart adjuvants.”191
Nanoparticles are exceedingly tiny, one nano-size (nm) equals one millionth of a meter. They do
not degrade until they are in the body and, therefore, do not require any preservatives for
maintaining shelf life. The nanoindustry claims that nanoparticles are non-toxic and far less
costly to develop than adjuvants and preservatives currently in vaccine use today.
Due to their minute size, they easily fuse with the membranes of a cell and can be designed to
target some of the body’s most essential specialized immune cells known as dendritic cells.
Nanoparticles are believed to induce “protective immunity at mucosal surfaces while avoiding
destructive inflammation.”192 Current common adjuvants trigger a different immune response
and do not stimulate cell-mediated immune responses within mucosal tissue. Briefly, a
nanoparticle—an otherwise natural particle of a biochemical—is artificially engineered at the
micro-structural level. In some instances, which is showing promise in nanomedicine, is to
engineer a hollow cavity, called a vault, in the particle in order to house a specific viral antigenic
protein(s). Given the extraordinary micro-size of these particles, they are easily absorbed by the
cells being targeted.
Nanotechnology and nanomedicine are very new sciences and still in their infancy.
Nanomedicine today is comparable to the very early stages of gene-technology in the early 90s.
While gene-technology for creating a new generation of state-of-the-art drugs based on DNA
science held great promise at the beginning, it was at that time so new that researchers were
journeying through unchartered waters.
In a press release in August 2009, BioSante Pharmaceuticals announced they had developed an
H1N1 flu vaccine that provided 100 percent protection after a single injection. Rather than
relying on older adjuvants, it includes a nanoparticle of calcium phosphate to quicken and
enhance the body’s immune response.193 What a reader of the nano-adjuvant discovery press
reports will find quite revealing is that, although the FDA, CDC, and major vaccine
manufacturers remain adamant about aluminum adjuvant safety, developers of nanoparticles are
quick to point out aluminum’s serious long term dangers in order to increase the value
nanomedicine’s potential for new drug and vaccine delivery systems.194
Nanoparticles have been explored as new adjuvants for several years. Scientists at Roswell Park
Cancer Institute and the Pharmaceutical Research Institute at Albany College of Pharmacy
developed a lactide-co-glycolide nanoparticle for delivering the Hepatitis B vaccine.195 In 2007,
researchers at EPFL in Lausanne, Switzerland reported that they developed and patented a
nanoparticle adjuvant for hepatitis and malaria.196 Athough there has yet to be developed a
suitable vaccine to combat Chlamydia trachomatis, a common sexually transmitted bacterial
agent, scientists at California NanoSystems Institute at UCLA are showing promise in a new
novel nano-adjuvant vaccine.197 Nanoparticles are also being researched and used in vaccines for
anthrax198 and tetanus.199 Oregon State University has now developed a nano-adjuvant out of
lecithin, the common food product and a major phytochemical found in eggs and many plants
such as soy, that creates an immune response six-fold stronger than conventional adjuvants in
vaccines against hepatitis B and tetanus.200
It is very predictable that conventional adjuvants will phase out within the next several years and
be replaced by nanoparticles. The National Institutes of Health Roadmap’s Nanomedicine
Initiative is heading full steam without a pilot to develop nanotechnology for “highly specific
medical intervention at the molecular scale for curing disease or repairing damaged tissues, such
as bone, muscle or nerve.201 The US National Cancer Institute is investing hundreds of millions
of dollars into the private sector for nanomedical research. The US National Nanotechnology
Initiatve has already provided more than $200 million for the NIH to advance the race against
European countries and Japan, which are also heavily invested in this high tech field. What is
particularly disturbing after a review of the NIH’s ten-year roadmap for nanomedicine is no
mention at all on safety studies on human health and its potential contributing factors for disease.
Instead, the entire initiative is being steered towards greater knowledge about nanoparticle
discovery, their structures, how they can be manipulated and their commercial value for drug
Nanotechnology has been used in chemical material development and products longer than for
medicine. Although very few health-risk studies have been conducted compared to the rapid
increase of commercial products now containing nanoparticles and nanotubes, there is very clear
reason to be alarmed. To just take one example, nanotubes, discovered in 1991 and found in
many products, have been found to produce lesions in the lungs very similar to asbestos’
resulting in mesothelioma, a deadly cancer.202
One form of nanoparticle known as quantum dots are used in imaging technology for diagnosing
diseases at even the sub-cellular level and have been used well before the development of nanoadjuvants. However, quantum dots have been shown to be highly toxic. We now hear of the
development of peptide amphiphiles, magnetic nanoparticles, enzyme-sensitive nanoparticle
coatings, and smart nanoprticle probes that are showing promise to replace some of our most
dangerous drugs, even chemotherapy.203
Even with these seemingly very positive advancements, there is very little experimental data to
confirm nanoparticles’ safety. Reporter Cathy Garber states, “The lack of knowledge about
nanoparticles might affect or interfere with the biochemical pathways and processes of the
human body is particularly troublesome.” Europe, which is more aware of environmental health,
has been more proactive than the United States in addressing the problem of nanotoxicity by
including nanotechnology in its International Risk Governance Council An article published in
the Medical Journal of Australia raises a crucial question about how to classify such particles in
the regulatory requirements of government health and environmental agencies. Given their recent
novelty, and the lack of experience and research on nanotechnology’s and nanomedicine’s
affects on human health and the environment, there remains no risk assessment protocol for
agencies and manufacturers to follow. Yet, as of the middle of 2007, 130 nanotech-based drugs
and delivery systems and 125 diagnostic devices and tests have entered pre-clinical, clinical or
commercial development in just 2.5 years.204 Gunter Oberdorster, professor of Toxicology and
Environmental Medicine at the University of Rochester warns, “There is a lot of hype
surrounding the promises of nanomedicine. Indeed many things look promising, but until now
there are only animal studies to show a proof of principle.”205 Prof. Oberdorster also raises
another fundamental concern being that there are no studies to show what might be
nanomedicine’s toxicological risks to the environment due to the disposal of nanowaste.
In the September 2009 issue of the peer-reviewed European Respiratory Journal, scientific
investigators at the prestigious Beijing Chaoyang Hospital seven women with exposure to
polyacrylate nanoparticles concluded the particles induced nonspecific pulmonary inflammation,
pulmonary fibrosis and foreign-body granulomas of pleuras. Upon inspection with electron
microscopy, nanoparticles were observed lodged in the cytoplasm and caryoplasm of pulmonary
epithelial and mesothelial cells.206
In 2005, scientists at the University of Michigan discovered that certain nanoparticles, known as
dendrimers, damaged cell membranes. In some instances the damage was severe enough to
cause cell death. Dendrimers are minute spheres with a wideth ten thousand times smaller than
the thickness of a human hair.207 These almost incomprehensibly small particles are now being
explored as a potential delivery system to more accurately bring drugs to specific cell targets in
the body. The Michigan researchers found that in high enough concentrations, these
nanoparticles punctured holes in cell membranes, thereby destroying them, and hence the cells as
well. In separate studies at the same institution, a different nanoparticle, polycationic polymers
that are electrically charged—already used in drug and gene delivery—resulted in similar
In a later 2007 study conducted at the University of Massachusetts, an undergraduate student,
Sara Pacheco, first uncovered a link between nanoparticles and DNA damage and cancer. Her
teams studies looked at two common nanoparticles found in electronic equipment, textiles and
sporting goods—silica and C60 fullerene—and their role in the onset of breast cancer cells. Her
comments very well summarize current nanotechnology and nanomedical product development,
“Unfortunately only a very small portion of research on nanoparticles is focused on health and
safety risks, or on threats to the environment… I am concerned because so many new
nanoparticiles are being developed and there is little regulation on their manufacture, use and
disposal.” The nano-industry places great emphasis on the size of a nanoparticle; the smaller the
particular, the better its micromolecular benefits for a specific purpose. However, according to
the University of Massachusetts study, the smaller the particle, the greater its toxicity.208
In the report published by the Oregon State University on the use of lecithin as an adjuvant, the
researchers state that their particle moves easily to the lymphatic system and that these particles
physically “look like” a pathogen by the immune system. Therefore, the immune system winds
to produce antibodies to fight them. Lecithin is a perfectly safe, non-toxic natural substance,
found in many foods, and known to reduce negative cholesterol. However, that is the lecithin as
it appears in the foods we eat such as soy or eggs. The question may be raised as to whether or
not lecithin injected as a nano-adjuvants will present a condition similar to the dangers
discovered when otherwise natural squalene is introduced to the body via injection, as opposed
to its normal route via ingestion. Squalene, an important natural nutrient that contributes to the
body’s joint health is found shark oil and foods such as wheat germ. As noted in the section on
squalene above, when it is injected into the body as a vaccine adjuvant, it has a contrary effect.
The body recognizes squalene as a foreign invader and develops antibodies to fight it. Thereafter,
squalene occurring naturally in our diet and body will pose an immune response that ushers forth
antibodies to attack it. This has contributed to various immune diseases such as arthritis and
lupus. If a nano-adjuvant of lecithin physically looks like a pathogen to the immune system, and
when injected, is there any assurance that the antibodies generated will not act against all lecithin
that enters the body?
Interview with Dr. Viera Scheibner. Broadcast WPFW, Washington DC. September 21, 2009.
Archived at http://garynull.org
“Many will die if Britain continues to rely only on my flu jab warns scientist” Scotsman.com
November 25, 2007.
Gary Null Interview with Jamie Murphy, December 18, 1997.
Gary Null Interview with Jamie Murphy, December 18, 1997.
W. James, Immunization: The Reality Behind the Myth, Massachusetts, Bergin & Gervey, 1988.
Gary Null Interview with Walene James, April 6, 1995.
A. Phillips, “Vaccination: Dispelling the Myths,” Nexus, October-November 1997.
Clinical Immunology and Immunopathology, 79(2), May 1996, p. 163-170.
Interview with Dr. Sherri Tenpenny. The Gary Null Show. WNYE, New York, August 21,
Reuters. “H1N1 has killed 2,837, virus has not mutated: WHO” September 4, 2009.
Reuters. “China faces grim situation as H1N1 escalates, minister.” September 8, 2009.
Walkom, Thomas. The Toronto Star. May 1, 2009.
Chossudovsky, Michel “Martial Law and the Militarization of Public Health: The Worldwide
H1N1 Flu Vaccination Program.” Globalresearch.ca July 30, 2009.
Interview with Dr. Sherri Tenpenny. The Gary Null Show. WNYE, New York, August 21,
“Was the Public Health Response to Swine Flu Alarmist?” Science Daily. September 4, 2009.
Neustaeder, Randal. The Vaccine Guide. North Atlantic Books: Berkeley, 2005.
Prevention and control of influenza: recommendations of the Advisory Committee on
Immunization Practices 9 ACIP. MMWR 4/21/95; 44 (rr-3).
Severyn, Kristine. “Flu Shots: Do They Really Work?” www.vran.org
Doshi, Peter. “Are US flu death figures more PR than science?” BMJ 2005; 331:1412 (10
Doshi, Peter. “Are US flu death figures more PR than science?” BMJ 2005; 331:1412 (10
Doshi, Peter. “Are US flu death figures more PR than science?” BMJ 2005; 331:1412 (10
Doshi, Peter. “Are US flu death figures more PR than science?” BMJ 2005; 331:1412 (10
Doshi, Peter. “Are US flu death figures more PR than science?” BMJ 2005; 331:1412 (10
Centers for Disease Control. “Influenza death statistics”.
www.cdc.gov/flu/about/diseases/us_flu-related_deaths.htm Accessed September 24, 2009.
Hall, Celia (Medical Editor). “Flu Vaccines ‘Not Worth the Bother’” The Telegraph, UK, October 27,
Statement on Influenza Vaccination for the 2004-2005 Season” Canada Communicable Disease
Report. Volume 31, ACS-6, 15 June 2005.
Hall, Celia (Medical Editor). “Flu Vaccines ‘Not Worth the Bother’” The Telegraph, UK, October 27,
Mass influenza vaccination in Ontario. Vittorio Demicheli: Rebuttal—responds to Dr. Schabas.
Canadian Medical Association Journal., January 9, 2001; 164(1).
James, Walene. Immunization: The Reality Behind the Myth. Pp. 118-119
“La grippe A ne devrait pas muter ensuper-virus” Le Monde FR. September 1, 2009.
Conversation with Wynne Alexander. Progressive Radio Network. August 19, 2009.
“Two Studies Find Flu Treatments Fall Short.” CTV.ca News Staff, September 22, 2005.
Dolgin E. “Flu Shot Guidelines Criticized.” Nature. August 20, 2009.
“German Health Expert Issues Novartis Swine Flu Vaccine Safety Warning” The Flu Cure.
August 23, 2009. www.theflucure.com
Interview with Dr. Viera Scheibner. Broadcast WPFW, Washington DC. September 21, 2009.
Archived at http://garynull.org
Webster P. Infectious disease experts expect the unexpected with respect to swine flu. CMAJ
2009 August 4; 181(3-4): E38-39.
Associated Press. July 24, 2009.
Quoted by Reuters, July 21, 2009.
Chossudovsky, Michel “Martial Law and the Militarization of Public Health: The Worldwide
H1N1 Flu Vaccination Program.” Globalresearch.ca July 30, 2009.
Lendman, Stephen. “Vaccination Myths and Truths” Global Research. August 3, 2009.
“Rapid Tests Often Wrong About Swine Flu” MSNBC News, August 6, 2009.
Quote from Dr. Neal Rau. Toronto Star, July 25, 2009.
“Grippe A: des blouses blanches anti-vaccin” SFR, France. September 18, 2009
“Half of GPs refuse swine flu vaccine over testing fears.” Daily Mail. August 25, 2009.
Interview with Wynne Alexander. Progressive Radio Network. August 19, 2009.
Kidder D, Scmitz R. Measures of costs and morbidity in the analysis of vaccine effectiveness based on
Medicare claims. In Hannoun C, et al. Eds. Options for the Control of Influenza 11. Amsterdam: Excerpts
Medica, 1993; 127-33.
Patrick, Jay. “Flu Vaccines ‘Worthless’ Says Eminent FDA Virologist.”
Neustaeder, Randal. The Vaccine Guide. North Atlantic Books: Berkeley, 2005.
Jefferson T, Smith S, Demicheli V, Harnden A, Rivetti A. Assessment of the efficacy and
effectiveness of influenza in healthy children: systemic review. The Lancet 2005; 365: 773-780.
Smith S, Demicheli V, Jefferson T, Harnden T. Matheson N, Di Pietrontonj C. Vaccines for
preventing influenza in healthy children. Cochrane Database Syst. Rev. 2004. 3:CD004879.
Reaney, Patricia. “No Evidence Flu Shots Work for Under-2s: Study. Reuters, September 22, 2005;
Jefferson, Tom. “Safety of influenza vaccines in children.” The Lancet, 2005. 366:803-804.
Dupre, Deborah. “The Big Lie: H1N1 Coincidences, Contradictions and Conspiring.” The Philadelphia
Examiner. August 27, 2009.
Bonhoeffer J, Kohl K, Chen R. The Brighton Collaboration: addressing the need for
standardized case definitions of adverse events following immunization. Vaccine 2002. 21: 298302.
Jefferson, Tom. “Influenza vaccination: policy versus evidence” BMJ. 333 28 October 2006.
Jefferson T, Smith S, Demicheli V, Harnden A, Rivetti A. Assessment of the efficacy and
effectiveness of influenza in healthy children: systemic review. The Lancet 2005; 365: 773-780.
Interview with Dr. Viera Scheibner. Broadcast WPFW, Washington DC. September 21, 2009.
Archived at http://garynull.org
CTV News Staff. “Unpublished Study Raises Questions About Flu Shot.” CTV.ca September
23, 2009.
Green A. “On the Flu Shot” July 2002. http://www.drggreene.com/21_985.html
Interview with Dr. Viera Scheibner. Broadcast WPFW, Washington DC. September 21, 2009.
Archived at http://garynull.org
Neustaeder, Randal. The Vaccine Guide. North Atlantic Books: Berkeley, 2005.
Severyn, Kristine. “Flu Shots: Do They Really Work?” www.vran.org
Prevention and control of influenza: recommendations of the Advisory Committee on
Immunization Practices 9 ACIP. MMWR 4/21/95; 44 (rr-3).
Flu prevention campaign underway. Health Care Financing Administration press office. HHS News,
1016/95. US Department of Health and Human Services.
Dowdle WR. Influenza Immunoprophylaxis after 30 years experience. In Nayak DP, ed. Genetic
Variation Among Influenza Viruses. New York: Academic Press, 1981: 525-34.
Napoli, Maryann. “How effective is the flu vaccine?” Medical Consumers. November 2004.
Rosenthal, Elisabeth. “Two studies question the effectiveness of flu vaccines.” New York Times,
September 21, 2005.
Stein, Rob. “Studies question flu vaccines” The Washington Post, reprinted in the Seattle Times,
September 25, 2005.
Paraphrased from reference in “Influenza : The Disease and the Vaccine.” Vaccine Risk Awareness
Network. www.vran.org
Neustaeder, Randal. The Vaccine Guide. North Atlantic Books: Berkeley, 2005.
Beyer WEP et al. “Influenza-epdiemie in een verpleeghuis door een virus dat niet in het vaccine was
opgenomen. Ned Tijdschr Geneeskd. 1993; 137/39: 1973-7.
105th International Conference of the American Thoracic Sociey, May 15-20, 2009 (quoted in ,
Sherri. “The Truth about Flu Shots”. Idaho Observer, June 1, 2009)
Tenpenny, Sherri. “The Truth about Flu Shots”. Idaho Observer, June 1, 2009.
Hambridge SJ, Glanz JM, France EK et al. “Safety of Trivalent Inactivated Influenza Vaccine in
Children 6 to 23 Months Old.” JAMA. 2006; 296: 1990-1997.
Yazbak, F. Edward. “Flu Vaccines Creating a Myth.” Vaccine Risk Awareness Network, November 11,
2006. www.vran.org
Yazbak, F. Edward. “Flu Vaccines Creating a Myth.” Vaccine Risk Awareness Network, November 11,
2006. www.vran.org
Yazbak, F. Edward. “Flu Vaccines Creating a Myth.” Vaccine Risk Awareness Network, November 11,
2006. www.vran.org
“Children who get the flu vaccine have three times risk of hospitalization for flu, study suggests”
Science Daily. May 20, 2009.
Christy C, Algine C, Auinger P, Pulcino T, Weitzman M. “Effectiveness of influenza vaccine for the
prevention of asthma exacerbations. Arch. Dis Child. 2004, 87: 734-5.
“Flu vaccination may triple risk for flu-related hospitalization in children with asthma” Medscape.com
May 25, 2009.
Initiative for Vaccine Research, World Health Organization. New vaccines against infectious
diseases: research and development status. April 2005; updated February 2006
World Health Organization. Development of new vaccines. Revised December 2006.
Kennedy Jr., Robert. “Vaccinations: Deadly Immunity” Salon.com, June 2005.
Greenberg M, Lai M, Hartel G, Wichems C, Gittleson C, Bennet J, Washington D, Basser R.
“Response after one dose of a monovalent influenza A (H1N1) 2009 vaccine – preliminary
report.” NEJM 2009; September 10; 361.
Smith, Michael. “Novartis Says Swine Flu Vaccine Works Quickly” MedPage Today.
September 3, 2009. http://www.medpagetoday.com/primarycare/vaccines/15817
Neuzil, Kathleen. “Pandemic Influenza Vaccine Policy: Considering the Early Evidence” NEJM
10.1056, September 10, 2009.
Richardson, Dawn. “Flu Vaccine: Stay Out of My Womb” October 8, 1999.
Branswell, Helen. “Canada to Buy Only Adjuvant-Free Vax for the Pregnant. The Canadian
Press. September 5, 2009.
Burgermeister, Jane. “No Data on the Use of Adjuvanted Flu Jabs on Pregnant Women Admist
Canada as it Changes “Swine Flu” Jab Policy. The Flu Cure. September 7, 2009.
Bergermeister, Jane, “German Health Expert Issues Novartis Swine Flu Vaccine Safety
Warning” The Flu Cure. August 23, 2009. www.theflucure.com
Ehrengut W, Allerdist H. Uber neurologische Komplikationen nach der Influenzaschutzimpfung.
Munch. Med Wschr. 1977; 119/705-710
Furlow TW. Neuropathy after influenza vaccination. The Lancet. 1977; i:253.
Ehrengut W, Allerdist H. Uber neurologische Komplikationen nach der Influenzaschutzimpfung.
Munch. Med Wschr. 1977; 119/705-710
Ehrengut W, Allerdist H. Uber neurologische Komplikationen nach der Influenzaschutzimpfung.
Munch. Med Wschr. 1977; 119/705-710
Miller H, Cendrowski W, Schapira K. Multiple sclerosis and vaccinations. BMJ. 1967. April 22: 210-3.
Hennessen W, Jacob H, Quast U. Neurologische Affektionen nach Influenza Impfung. Der Nervenarzt.
1978. 49/90-96
Stohr M, Mayer K. Nuerologische Erkrankungen nach Grippeschutzimpfung. Med. Welt. 1976: 27/912914
Hennessen W, Jacob H, Quast U. Neurologische Affektionen nach Influenza Impfung. Der
Nervenarzt. 1978. 49/90-96
Hennessen W, Jacob H, Quast U. Neurologische Affektionen nach Influenza Impfung. Der
Nervenarzt. 1978. 49/90-96
Ehrengut W, Allerdist H. Uber neurologische Komplikationen nach der Influenzaschutzimpfung.
Munch. Med Wschr. 1977; 119/705-710
Hennessen W, Jacob H, Quast U. Neurologische Affektionen nach Influenza Impfung. Der
Nervenarzt. 1978. 49/90-96
Hennessen W, Jacob H, Quast U. Neurologische Affektionen nach Influenza Impfung. Der
Nervenarzt. 1978. 49/90-96
Hennessen W, Jacob H, Quast U. Neurologische Affektionen nach Influenza Impfung. Der
Nervenarzt. 1978. 49/90-96
Ehrengut W, Allerdist H. Uber neurologische Komplikationen nach der Influenzaschutzimpfung.
Munch. Med Wschr. 1977; 119/705-710
Wells CEC. British Medical Journal. 1971. 2: 755.
Macfarlane, Jo. “Swine flu vaccine linked to deadly nerve disease.” Global Research. August
16, 2009. www.globalresearch.ca.
“Guillain-Baree Syndrome” Wikipedia. Accessed September 24, 2009.
Neustaeder, Randal. The Vaccine Guide. North Atlantic Books: Berkeley, 2005.
Macfarlane, Jo. “Swine flu vaccine linked to deadly nerve disease.” Global Research. August
16, 2009. www.globalresearch.ca.
Engdahl, F. William. “Swine Flu Vaccine Linked to Paralysis.” Globalresearch.ca
September 8, 2009.
“Neurologists urged to watch for rare swine flu vaccine side effect.” The Oregonian.
September 1, 2009
Rattingan, Pat. Vaccination: Assault on the Species.
O’Shea Tim. The Sanctity of Blood: Vaccination is Not Immunization. Central Horizons:
Reno, 2007 p. 98.
“Before You Get That Flu Shot” Health Sciences Institute. www.HSIBaltimore.com
Pollack, Andrew. “Benefit and Doubt in Vaccine Additive” New York Times. September 22,
O’Shea Tim. The Sanctity of Blood: Vaccination is Not Immunization. Central Horizons:
Reno, 2007 p. 98.
Pollack, Andrew. “Benefit and Doubt in Vaccine Additive” New York Times. September 22,
Product Information Insert. Fluarix, GlaxoSmithKline, August 2007
Product Information Insert, Flumist, Medimmune, September 2007
Ho, Mae-Wan, Cummins, Joe. “The vaccines are far more deadly than the swine flu”. Global
Research. August 21, 2009. www.globalresearch.ca
A. Phillips, “Vaccination: Dispelling the Myths,” Nexus, October-November 1997.
Jamie Murphy, What Every Parent Should Know About Childhood Immunization, Boston,
Earth Healing Products, 1993, p. 5.
The following quotes and events were taken from Roberts, Janine. Fear of the Invisible: How
Scared Should We Be of Viruses and Vaccines, HIV and AIDS Impact Investigative Media
Productions: Bristol UK, 2009; and from an interview with Janine Roberts. The Gary Null
Show. The Progressive Radio Network and WNYE-New York on August 19, 2009.
“Serious Questions Regarding the Safety and Efficacy of the Influenza Vaccine” Vaccine Risk
Awareness Network. http://vran.org/about-vaccines/specific-vaccines/influenza-vaccine-flushot/influenza-nursing-home-deaths/
Ho, Mae-Wan, Cummins, Joe. “The vaccines are far more deadly than the swine flu”. Global
Research. August 21, 2009.
Thimerosal in Vaccines: A Joint Statement of the American Academy of Pediatrics and the
Public Health Service. MMWR 07/09/1999; 48(26):563.
U.S Food and Drug Administration. Thimerosal in vaccines. Updated September 25, 2006.
Centers for Disease Control and Prevention. Mercury and vaccines (thimerosal). Modified
October 12, 2006.
“The evidence for the safety of thiomersal in newborn and infant vaccines”. Clements CJ.
Vaccine. 2004 May 7;22(15-16):1854-61
Thimerosal in Vaccines: A Joint Statement of the American Academy of Pediatrics and the Public
Health Service MMWR. Vol 48, No 26;563 07/09/1999
U.S. Food and Drug Administration. Thimerosal in vaccines. Updated September 25, 2006.
U.S. Food and Drug Administration. Thimerosal in vaccines: frequently asked questions. Last
updated September 29, 2006.
Tim O’Shea The Sanctity of Blood: Vaccination is not Immunization. Central Horizons:
Reno, 2007 pg. 134.
Widespread neuronal degeneration in rats following oral administration of methylmercury during the
postnatal developing phase: a model of fetal-type minamata disease. Sakamoto M, et al. Brain Res 1998
Feb 16;784(1-2):351-4
Neurobehavioral effects from exposure to dental amalgam Hg(o): new distinctions between recent
exposure and Hg body burden. Echeverria D, et al. FASEB J 1998 Aug; 12(11):971-80.
A review of methylmercury and child development. Myers GJ, et al. Neurotoxicology 1998
Prenatal methylmercury exposure and children: neurologic, developmental, behavioral research. Myers
GJ, et al. Environ Health Perspect 1998 Jun;106 Suppl 3:841-7
Geier DA, Geier MR. A two-phased population epidemiological study of the safety of
thimerosal-containing vaccines: a follow-up analysis. Med Sci Monit 2005; 11(4):CR160-170.
Kirby D. Evidence of Harm: Mercury in Vaccines and the Autism Epidemic: A Medical
Controversy. New York; St. Martin’s Press; 2005.
Holmes AS, Blaxill MF, Haley BE. Reduced levels of mercury in first baby haircuts of
autistic children. Int J Toxicol 2003; 22(4):277-285.
Bradstreet J, Geier DA, Kartinel JJ, et al. A case-control study of mercury burden in children
with autistic spectrum disorders. J Am Phys Surg 2003; 8(3):76-79.
James SJ, Cutler P, Melnyk S, et al. Metabolic biomarkers of increased oxidative stress and
impaired methylation capacity in children with autism. Am J CLin Nutr 2004; 80(6):1611-1617.
Hviid A, Stellfeld M, Wohlfahrt J, et al. Association between thimerosal-containing vaccine
and autism. JAMA 2003; 290(13):1763-1766.
Stehr-Green P, Tull P, Stellfeld M, et al. Autism and thimerosal-containing vaccines: lack of
consistent evidence for an association. Am J Prev Med 2003; 25(2):101-106.
Madsen KM, Lauritsen MB, Pedersen CB, et al. Thimerosal and the occurrence of autism:
negative ecological evidence from Danish population-based data. Pediatrics 2003; 112(3 Pt
Immunization Safety Review Committee. Immunization safety review: vaccines and autism.
A-CHAMP (Advocates for Children’s Health Affected by Mercury Poisoning). State
legislation to ban mercury in vaccines. www.a-champ.org/state.html.
Centers for Disease Control and Prevention. Vaccines timeline. Last modified April 29, 2005.
Centers for Disease Control and Prevention. Availability of thimerosal-free vaccines. Last
moidifed May 11, 2004.
Thimerosal in vaccines: frequently asked questions, op. cit.
Initiative for Vaccine Research, World Health Organization. New vaccines against infectious
diseases: research and development status. April 2005; updated February 2006
Institute of Medicine. Vaccines and Autism, Washington DC: The National Academies Press, 2004.
A review of thimerosal (merthiolate) and its ethylmercury breakdown product: specific
historical considerations regarding safety and effectiveness. Geier DA, Sykes LK, Geier MR. J
Toxicol Environ Health B Crit Rev. 2007 Dec;10(8):575-96.
An assessment of the impact of thimerosal on childhood neurodevelopmental disorders.
Geier DA, Geier MR. Pediatr Rehabil. 2003 Apr-Jun;6(2):97-102.
Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication.
Geier MR, Geier DA. Exp Biol Med (Maywood). 2003 Jun;228(6):660
A comparative evaluation of the effects of MMR immunization and mercury doses from
thimerosal-containing childhood vaccines on the population prevalence of autism. Geier DA,
Geier MR. Med Sci Monit. 2004 Mar;10(3):PI33-9
Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a
follow-up analysis. Geier D, Geier MR. Int J Toxicol. 2004 Nov-Dec;23(6):369-76.
A two-phased population epidemiological study of the safety of thimerosal-containing
vaccines: a follow-up analysis. Geier DA, Geier MR. Med Sci Monit. 2005 Apr;11(4):CR16070. Epub 2005 Mar 24.
An assessment of downward trends in neurodevelopmental disorders in the United States
following removal of Thimerosal from childhood vaccines. Geier DA, Geier MR. Med Sci
Monit. 2006 Jun;12(6):CR231-9. Epub 2006 May 29.
A case series of children with apparent mercury toxic encephalopathies manifesting with
clinical symptoms of regressive autistic disorders. Geier DA, Geier MR. J Toxicol Environ
Health A. 2007 May 15;70(10):837-51
A prospective study of thimerosal-containing Rho(D)-immune globulin administration as a
risk factor for autistic disorders. Geier DA, Geier MR. J Matern Fetal Neonatal Med. 2007
Dupre, Deborah. “Squalene laced H1N1 vaccination, pharmaceutical warfare” Philadelphia Examiner.
August 18, 2009.
Engdahl, F. William. “Swine Flu Vaccine Linked to Paralysis.” Globalresearch.ca
September 8, 2009.
Holm BC, Svelander L, Bucht A, Lorentzein JC. The arthritogenic adjuvant squalene does not
accumulate in joints but gives rise to pathogenic cells in both draining and non-draining lymph
nodes. Clin Exp Immunol. 2002 March 127(3): 430-435
Holm BC, Lorentzein JC, Bucht A. Adjuvant oil induces waves of arthriogenic lymph node
cells prior to arthritis onset. Clin Exp. Immunol. 2004 July 137(1): 59-64.
Carlson BC, Jansson AM, Larsson A, Bucht A, Lorentzein JC. The endogenous adjuvant
squalene can induce a chronic T-cell mediated arthritis in rats. Am J. Pathol. 2000 June 156(6):
Glenn EM, Gray J. Adjuvant induced polyarthritis in rats. Am. J Vet Res. 1965 September
26(114):1180-1194; Pearson CM, Wood FD. Passive transfer of adjuvant arthritis by lymph
node or spleen cells. J. Exp Med. 1964 October 1:120: 547-560; Zamma T. Adjuvant-induced
arthritis in the temporomandibular joint of rats. Infect. Immunol. 1983 March 39(3): 1291-1299
Watson, Paul Joseph. “Government Swine Flu Advisor On Vaccine Maker Payroll”
Globalresearch.ca July 27, 2009.
Matsumoto, Gary. Vaccine A: The Covert Government Experiment That’s Killing Our Soldiers and
Why GIs are Only the First Victims. Basic Books, 2004.
Watson, Paul Joseph. “Government Swine Flu Advisor On Vaccine Maker Payroll”
Globalresearch.ca July 27, 2009.
Newman, Alex. “Risks of the Swine Flu Vaccine (Experimental adjuvant squalene implicated in
autoimmune disorders” September 3, 2009. http://thenewamerican.com
Der Spiegel. http://www.spiegel.de/international/germany.0,1518,640853-2,00.html
Webster P. Infectious disease experts expect the unexpected with respect to swine flu. CMAJ
2009 August 4; 181(3-4): E38-39. Del Guidice G, Rappuoli R, Fragapane E, Henriksson T,
Bugaarini R, Palla E. Vaccines with the MS59 adjuvant do not stimulate antibody responses
against squalene. Clin. Vaccine Immunol. 2006 September 11(9): 1010-1013.
Press Release: Merck’s Gardasil Vaccine Not Proven Safe for Little Girls. National Vaccine
Information Center. June 27, 2006
Food and Drug Administration. May 18, 2006. FDA Background Document for Vaccines and
Related Biological Products Advisory Committee: Gardisil HPV Quadrivalent Vaccine
Merck and Co.. May 18, 2006. Merck Briefing Document for Vaccines and Related
Biological Products Advisory Committee: Gardasil HPV Vaccine
Press Release, NVIC, op cit.
Press Release, Judicial Watch Uncovers Three Deaths Relating to HPV Vaccine. May 23,
Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation
of betamyloid protein. Kawahara M et al. Brain Res. Bull. 2001, 55, 211-217
Aluminum adjuvanted vaccines transiently increase aluminum levels in murine brain tissue.
Redhead K et al. Pharacol. Toxico. 1992, 70, 278-280
Determination of aluminum levels in the kidney, liver and brain of mice treated with
aluminum hydroxide. Sahin G et al. Biol. Trace. Elem Res. 1994. 1194 Apr-May;41 (1-2): 12935
Macrophagaic myofastitis lesions assess long-term persistence of vaccine-derived aluminum
hydroxide in muscle. Gherardi M et al. Brain. 2001. Vol. 124, No. 9, 1821-1831
Marophagic myofastititis associated with vaccine derived aluminum. Shingde M et al. MJA.
2005. 183(3): 145-146
Ho, Mae-Wan, Cummins, Joe. “The vaccines are far more deadly than the swine flu”. Global
Research. August 21, 2009. www.globalresearch.ca
Petrovsky N, Heinzel S, Honda Y, Lyons AB. “New age vaccine adjuvants, friend or foe?” BioPharm
International 2 August 2007.
Offit, Paul. “Do vaccines contain harmful preservatives, adjuvants, additives and residuals.”
Pediatrics. December 2003. 112(6): 1394-1397.
Engdahl, William “Nano Particles used in untested H1N1 Swine Flu vaccines.” Global Research,
September 13, 2009. www.globalresearch.ca
“Nanoparticle Delivery System Developed to Induce Immunity to Certain STDs” Science
Daily. May 4, 2009.
Champion et al. A vault nanoparticle vaccine induces protective mucosal immunity. PLoS
ONE, 2009; 4(4): e5409.
“BioSante Pharmaceuticals Reports 100% Protection from H1N1 Challenge when Using
BioVant Adjuvanted Vaccine” Press Release. August 17, 2009. www.biosantepharma.com
“Calcium Phosphate Nanoparticle Based Flu Vaccine from BioSante (press release).
Bharali D, Pradhan V. Elkin G. Qi W, Hutson A, Mousa S, Thanavala Y. “Novel
nanoparticles for the delivery of recombinant hepatitis B vaccine” Nanomedicine. December
2008. 4 (4): 311-317
Reddy S, van der Vlies A, Simeoni E, Angeli V, Randolph G, O’Neil C, Hubbell J. Exploiting
lymphatic transport and complement activation in nanoparticle vaccines. Nature Biotechnology
2007. 25, 1159-1164.
Champion et al. A vault nanoparticle vaccine induces protective mucosal immunity. PLoS
ONE, 2009; 4(4): e5409.
“Anthrax vaccine uses nanoparticles to produce immunity” Medical News Today. August 17,
2007. www.medicalnewstoday.com
“New Adjuvant Could Hold Future of Vaccine Development.” Science Daily. September 15,
“New Adjuvant Could Hold Future of Vaccine Development.” Science Daily. September 15,
“Nanomedicine” NIH Roadmap for Medical Research. www.nihroadmap.nih.gov
Chang K. “In study, researchers find nanotubes may pose health risks similar to asbestos”
New York Times. May 21, 2008.
Garber C. “The potential and the pitfalls of nanomedicine” Nanowerk Spotlight. May 7, 2007.
Garber C. “The potential and the pitfalls of nanomedicine” Nanowerk Spotlight. May 7, 2007.
Newsweek Garber C. “The potential and the pitfalls of nanomedicine” Nanowerk Spotlight.
May 7, 2007.
Song Y, Li X, Du X. Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and
granuloma. European Respiratory Journal. 2009, September. 34(3): 559-567
“Probing the Promise and Perils of Nanaoparticles.” Science Daily. March 25, 2005.
“Nanoparticles Can Damage DNA, Increase Cancer Risk.” Science Daily. April 18, 2007.
Fly UP